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 The outer surface lipoprotein (osp) layer forms an interface between the internal and the external 
environment of the Lyme disease spirochete, Borrelia burgdorferi. The homeostatic maintenance of the 
osp layer effectuates adaptation of B. burgdorferi as it gets transmitted from the tick vector to a mammalian 
host and vice-versa. However, the regulation of the outer surface lipoproteins (osps) is still a conundrum 
for borrelia scientists. Part of this dissertation inquires about the homeostatic maintenance of the osp layer. 
We found that the deletion of the dominantly expressed tick phase osp, OspA, induces expression of two 
other osps. OspD, and BBJ41. Also, increased expression of OspC was seen in borrelia mutants lacking 
OspA, OspD, and BBJ41. These results suggest constant osp layer maintenance, irrespective of the presence 
or the absence of the dominant Osps, like OspA and OspC. Furthermore, our conclusive electron 
microscopic study demonstrates that the overall density of the osp layer remains identical in wild type and 
mutant B. burgdorferi, lacking either several osps or the dominantly expressed OspA.  
 OspA is abundantly expressed on the borrelial surface as it persists in an unfed tick. A blood meal causes 
rapid downregulation of OspA as B.burgdorferi prepares to infect the mammalian host. The downregulation 
of OspA is speculated to be regulated by an unknown repressor protein. The remaining part of this 
dissertation pertains to the investigation of this unknown repressor protein for ospA. The borrelia oxidative 
stress regulator protein, BosR, has been attributed with an indirect role in OspA downregulation. However, 
due to its homolgy with a family of transcriptional repressors, BosR is more likely to cause direct repression 
of OspA. Therefore, we investigated the direct interaction of BosR and the ospA regulatory region. The 
DNA binding experiments demonstrated that borrelia oxidative stress regulator, BosR, binds directly to the 
cisI and cisII regulatory regions of ospA promoter. Thus, conclusively, BosR acts as a repressor protein 




BACKGROUND AND OBJECTIVES  
 
Literature review 
The Lyme disease agent, Borrelia burgdorferi is a microaerophilic, gram negative motile 
bacteria, which belongs to an ancient phylum: spirochaetes, genus: Borrelia, class: Spirochaetes, 
order: Spirochaetales, and family: Spirochaetaceae (Paster and Dewhirst 2000, Brisson et al. 
2012).  
The term spirochete emanates from the helical/serpentine morpholgy of the bacteria. In nature 
the spirochetes may be free dwelling or exist within a host, a very few spirochetes act as a 
pathogen (Paster and Dewhirst 2000). Borrelia burgdorferi is one of the pathogenic genus under 
spirochetes causing tick borne disease called the Lyme disease (Paster and Dewhirst 2000).  
In 1982, the first isolate of Borrelia burgdorferi was obtained (Burgdorfer et al. 1982). Since 
then many borrelia isolates have been obtained throughout the world. The genetic analysis of the 
different isolates have resulted in formation of the Borrelia burgdorferi sensu lato complex. This 
complex includes up to 18 Borrelia species (Stanek and Reiter 2011), only three of these are 
known to be true human pathogens, namely:  B. burgdorferi sensu stricto, B. garinii, and B. 
afzelii. While B. garinii and B. afzelii are predominant Lyme disease agents in Europe, B. 
burgdorferi sensu stricto causes Lyme disease in the North America (Baranton et al. 1992). 




    
Figure 1.1. Genospecies of Borrelia burgdorferi and their tick vectors and location:  Taken from 
(Steere, Coburn, and Glickstein 2004) depicts worldwide distribution of several members of 
Borrelia burgdorferi sensu lato complex along with principal tick vectors and location 
 
Lyme disease recognition in the United States 
The first Lyme disease cases were reported in the form of juvenile rheumatoid arthritis amongst 
a group of children from Lyme village, Connecticut in year 1976 (Steere et al. 1977, Steere 
1989). In the years that followed, the doctors and scientists proved that Lyme disease was 
transmitted by bite from an infected Ixodes tick (Steere 1989) and caused by a spirochete called 
Borrelia burgdorferi (Burgdorfer et al. 1982, Steere 1989). 
Even after three decades of its discovery, today Lyme disease stands as most commonly reported 
vector borne disease (Steere 2006). According to CDC “Lyme disease is the most commonly 
reported vector borne illness in the United States in 2012, it was the 7th most common 
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Nationally Notifiable disease” (http://www.cdc.gov/lyme/stats/index.html). As shown in figure 
1.2 Lyme disease continues its trend of newly reported cases in past 10 years, no significant 
control of the disease has been achieved. 
 
Figure 1.2. Reported cases of Lyme disease by year, United States, 2003-2012:  
(Centers for Disease Control and Prevention National Center for Emerging and Zoonotic 
Infectious Diseases Division of Vector-Borne Diseases, last reviewed September, 2013) 
http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html. 
The number of confirmed cases ranged from a low of 19,804 in 2004 to high of 29,959 in 2009. 
 *National Surveillance case definition revised in 2008 to include probable cases; 
(detail:http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/lyme_disease_2008.htm) 
 
The comparison of reported cases in figure 1.4 and figure 1.5 show visible increase in 
distribution of the reported cases since year 2001 to 2012, the total number of cases reported in 
the years 2001- 2011 varied  from 17029 - 24364,   (Centers for Disease Control and Prevention, 




Figure 1.3. Map showing Lyme disease  reported case distribution in year 2001 (Centers for 
Disease Control and Prevention, http://www.cdc.gov/lyme/stats/maps/interactiveMaps.html ) 
 
 
Figure 1.4. Map showing Lyme disease reported case distribution in year 2012 (Centers for 




Clinical symptoms  
In order to transmit the Lyme borrelia and initiate appearance of the cutaneous manifestation, the 
Ixodes tick needs to complete at least 36-48 hours on its host (Peavey and Lane 1995). One of 
the studies indicated even lower tick attachment time (24hrs) may be required in order to 
transmit Lyme borrelia (Piesman et al. 1987). While up to 90% people show erythema migrans at 
the site of tick bite (Gerber et al. 1996) (Krause et al. 1996), more than half of the infected 
people fail to detect or recall the tick bite, also the nymph stage of tick is hard to see and be 
recognized (Asbrink and Hovmark 1988). The lesion of erythema migrans initiates as a small red 
macule from the tick bite site and within a week of bite, migrates outwardly leading to formation 
of typical “Bull’s eye rash” figure1.6 (Nadelman et al. 1996). However, erythema migrans 
cannot be considered as a diagnostic lesion for Lyme disease (Asbrink and Hovmark 1988), as 
some times rash may lack the central clearance, appear similar to other tick bites (Kirkland et al. 
1997), or appear as a migrating lesion away from the unnoticed initial tick bite site (Nadelman et 
al. 1996).  
 
Figure 1.5. Erythema migrans leision with central clearing (bull’s eye rash): Picture from Centre 





Early classification for clinical symptoms of Lyme disease was given by Steere et al. in 1983. 
Under this classification the course of Lyme disease was divided into three stages: Stage one of 
Erythema migrans, stage two including meningitis or Bell's palsy, and stage three showing 
arthritis. As there was overlap of symptoms under different stages of above early classification 
the clinical manifestations of Lyme disease was reclassified by Asbrink & Hovmark in 1988. 
The new classification was based on classification for Syphilis caused by spirochete called 
Treponema pallidum. Under this classification, clinical manifestation for Lyme disease has been 
divided into three broad stages (Nadelman and Wormser 1998, Steere 1989, Yoshinari, Steere, 
and Cossermelli 1989): 
1. Stage one: The early localized stage (Asbrink and Hovmark 1988), occurs within 3-30 days of 
the infectious Ixodes tick bite. Main symptoms seen are erythema migrans, malaise, headache, 
fever, myalgia, and fever (viral fever like signs) (Steere et al. 1983). 
2. Stage two: The early disseminated stage (Asbrink and Hovmark 1988), ensues within days to 
weeks. This stage is characterized by borrelia lymphocytoma, meningo-polyneuritis, and 
multiple systemic effects like: Atrioventricular block (Steere et al. 1980), multiple erythema 
migrans, myalgia, arthralgia, facial or Bell's palsy (loss of muscle tone on one or both sides of 
the face, figure 1.6), and severe headaches and neck stiffness due to meningitis (inflammation of 
the spinal cord).(Ho, Melanson, and Desai 2012) 
3. Stage three: The late stage (Asbrink and Hovmark 1988) or stage of persistent infection, 
known to occur months to years of initial tick bite. This stage includes acrodermatitis chronica 
atrophicans, monoarticular or oligoarticular arthritis, figure 1.7 (Steere et al. 1977) or chronic 





Figure 1.6. Loss of facial muscle tone on one or both sides: Bell’s palsy. Can be seen in early   
disseminated stage (picture from Centre for Disease Control and Prevention, CDC- Division of 
Vector-borne Infectious Diseases http://www.cdc.gov/lyme/signs_symptoms/index.html). 
 
 
Figure 1.7.  Lyme arthritis, painful swelling of either single or both knee joints can ensue in late 
disseminated stage. Picture from CDC- Division of Vector-borne Infectious Diseases 
  
Diagnosis of Lyme disease 
In endemic regions , the clinical signs like erythema migrans (Bull’s eye rash ) have preliminary 
diagnostic value, however, the culturing of Borrelia burgdorferi from these leisions enables 
definitive diagnosis (Tugwell et al. 1997). The diagnostic cultures can be obtained from 
erythema migrans, acrodermatitis, and occasionally from plasma and cerebrospinal fluid 
samples. However, the patients in late stage of the disease may be diagnosed based on 
Polymerase Chain Reaction (PCR) for detection of borrelia in joint fluid (Nocton et al. 1994). In 
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suspected cases for extra cutaneous Lyme disease tissues having borrelia may be inaccessible for 
culturing and hence serum based diagnosis is of greater value, these tests include Enzyme Linked 
Immunosorbent Assay (ELISA), immunoblot or western blot test, and indirect 
immunofluorescence assay (Lebech 2002, Tugwell et al. 1997). 
The Center for Disease Control and Prevention has recommended two step (Figure 1.8) diagnosis 
of Lyme disease using blood sample for detection of antibodies against Borrelia burgdorferi.   
Under the first step testing, either the Enzyme Immunoassay (EIA) or the Immunofluorescence 
Assay (IFA) test is performed. If the first test is negative then no further test is conducted. In 
case of an indeterminate or positive result, second test, the Western blot or immunoblot is 
performed. If both the tests are positive only then the sample is considered true positive. 
However, serum based tests are not considered reliable by many scientists working with the 
Lyme disease (Steere et al. 1993, Hofmann 1996), as antibodies may be absent in patients with 
early disease symptoms, while, antibodies may persist even after years after clinical recovery 
(Gajovic et al. 2010), further patients treated do not show presence of antibodies. Due to 
shortcomings in serum based diagnosis a recent improved ELISA test has been recommended , 
in this test recombinant chimeric Borrelia burgdorferi proteins are used for detection (Gomes-
Solecki et al. 2000).  
The search and standardization for an adequate diagnosis for Lyme disease continues and 
someday CDC two tier test recommendation may be changed, covering for distinct Lyme disease 
diagnostic requirements (Aguero-Rosenfeld et al. 2005, Wormser et al. 2013). But at this time 
the following Two–Tier decision system (Figure 1.8) recommended by CDC continues as 




Figure 1.8. Two-tier testing decision Tree from Centre for Disease Control and Prevention 
(http://www.cdc.gov/lyme/diagnosistesting/LabTest/TwoStep/index.html) 
 
Treatment of Lyme disease 
In the early Lyme disease stage the serum testing is of limited utility , as there is no IgG in 
circulation during first 14 days of infection (Dressler et al. 1993). If an engorged Ixodes nymphal 
tick is found attached then a single 200mg dose of doxycycline is curative (Nadelman et al. 
2001). In apparent erythema migrans the antibiotic treatment is continued for 10-20 days using 
doxycycline, both in adults and children above 8 years of age. Amoxicillin is considered best 
choice in children younger than 8 years (Wormser et al. 2003). The patients treated with 
antibiotics during the initial phase of the disease tend to have reinfection with Lyme disease 
(Bennet and Berglund 2002). Intravenous clindamycin, oral atovaquone, or oral quinine, and 
azithromycin is considered effective in people having coinfection with other vector-borne agents 
like Babesia or Anaplasma (Brown et al. 1995). In neurologic symptoms of Lyme disease, 
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intravenous antibiotic therapy with ceftriaxone is considered effective (Oschmann et al. 1998). 
Lyme arthritis can be treated with oral antibiotics doxycycline or amoxicillin, however treated 
patients can still develop either neuronal Lyme disease, or persistent arthritis with no effect of 
antibiotics (Steere et al. 1994). 
Lyme disease transmission  
Lyme disease is a zoonotic disease transmitted amongst ticks of Ixodes ricinus complex and a 
mammalian host (Anderson 1989). Borrelia burgdorferi infects the mammalian host as the 
Ixodes tick vector takes up the blood meal (Steere, Broderick, and Malawista 1978, Wallis et al. 
1978). Though Lyme disease is considered as a zoonosis, humans are incidental hosts and once 
infected act as dead end host (Baum 2008). 
The first B. burgdorferi isolate was found in an ixodid tick from Shelter island at New York in 
1981 (Burgdorfer, Barbour et al. 1982). The ixodes ticks thrive well in the temperate climate of 
the northern hemisphere, this is also true for Borrelia burgdorferi surviving amongst various 
mammalian reservoir hosts (Radolf et al. 2012). The distribution of ticks vary with geographical 
location and climatic conditions, while Ixodes scapularis is main vector for northeastern and 
upper mid-western United States, Ixodes pacificus is common in the far western United States, 
Ixodes persulcatus is found in Asia and Ixodes ricinus in Eurasia (Lane, Piesman, and 
Burgdorfer 1991).The change in land use patterns in the late 20th century, particularly the 
deforestation followed by reforestation in northeastern and mid-western parts of United States 
has provided optimum conditions for Lyme disease vector to propagate (Barbour 1998, Chen et 
al. 2005). 
Ixodes scapularis, commonly known as the black legged tick was first described in 1979 by 
Spielman et al. (Spielman et al. 1979). The different life stages of I. scapularis, include eggs, 
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larvae, nymphs, and dimorphic adults (Figure 1.10). The detailed two year life cycle for Lyme 
disease vector has been shown in figure 1.9. The trans-stadial transmission of Borrelia 
burgdorferi from larval stage to nymphal stage  and a blood meal at each developmental stage, 
on same reservoir host species ensure the horizontal transmission of infection from infected to 
uninfected developmental stage (Burgdorfer 1984b, Drouin, Glickstein, and Steere 2004, Levine, 
Wilson, and Spielman 1985). 
The questing activity of nymphs coincides with the high outdoor human activities, further the 
small size of nymphs help them attach undetected, due to these advantages, the tick vector 
nymphs are critical to cause high incidence of Lyme disease in humans, especially during late 
spring and early summer (Lane, Piesman, and Burgdorfer 1991). 
 The developmental stages of tick vector have a broad host range including small mammals and 
birds (Anderson 1989, 1988). In its current cycle within the north eastern United States, 
Peromyscus leucopus (the white footed mouse) acts as the main reservoir host for  the nymphal 
and larval stages of ticks (Anderson and Magnarelli 1980, Anderson et al. 1985). The adult ticks 
are known to feed on larger animals especially white tailed deer (Odocoileus virginianus) 
(Bosler et al. 1984, Carey, Krinsky, and Main 1980, Spielman et al. 1979). 
Adaptation of Borrelia burgdorferi  
In an unfed tick vector B. burgdorferi (Figure 1.11) remains dormant within the midgut. In 
response to blood meal the spirochetes move from hemocoel to the salivary gland (Ribeiro et al. 
1987). It is during the blood meal that borrelia infects the mammalian host through tick saliva 
(Burgdorfer 1984a, Schwan and Piesman 2000). During its journey from tick midgut to the 
mammalian host environment B. burgdorferi undergoes several adaptive changes (Schwan and 
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Piesman 2000, Schwan et al. 1995). Most eminent of these adaptations is the rapid change in the 




Figure 1.9. Two year cycle of Lyme disease vector: at least one blood meal is taken at every 
stage, the adult female tick lay eggs in the spring after feeding on a large mammalian host, in 
summer eggs hatch to larvae which feed on small mammals and birds and molt into nymphs 
during next spring, these nymphs again feed on a mammalian host during late spring or early 
summer and molt into adults the following fall. It is during the nymph feeding season that 
humans become incidental host as the peak outdoor activities coincide with the questing nymphs. 






Figure 1.10. Comparative morphology of the different life stages of the Lyme disease vector 
Ixodes Scapularis (CDC- Division of Vector-borne Infectious Diseases, last modified January 
11, 2013, http://www.cdc.gov/lyme/transmission/index.html) 
A B 
Figure1.11. Morphology of Borrelia burgdorferi (A) Shows spiral morphology of Borrelia 
burgdorferi.(Rosa, Tilly, and Stewart 2005) Borreliae are 10-30µm long and .2-.3µm wide and 
have 7-11 periplasmic flagella imparting spiral shape (Burgdorfer et al. 1982) (B) “Schematic 
representation of a spirochete” from (Canale-Parola 1977) shows outer envelope in broken line , 
protoplasmic cylinder in solid line which follows along outer envelope, and thin solid line 
indicates the axial fibrils. 
 
Unlike other double membraned gram negative bacteria, that express lipopolysaccharide on their 
outer-membrane, borrelia express proteins covalently linked to lipids known as outer surface 
lipoproteins (osps) (Barbour and Hayes 1986, Bergstrom, Bundoc, and Barbour 1989, Brandt et 
al. 1990). The outer surface lipoproteins form an interface between borrelia’s internal and 




Figure1.12. Comparative membrane structures of Gram-positive, Gram-negative and B. 
burgdorferi. The outer membrane of borrelia is markedly distinct from Gram-positive and other 
Gram-negative bacteria. The borrelial outer membrane is fluid, fragile, and lacks 
Lipopolysaccharide, instead it is adorned with several lipoproteins anchored to the outer 
membrane by process called lipidation.  
 
As the external environment alternates from tick midgut to mammalian host, the osps play 
critical role in survival of borrelia (Brandt et al. 1990, Bergstrom, Bundoc, and Barbour 1989). 
As shown in figure 1.13, in an unfed tick, Borrelia burgdorferi remains low in number and 
expresses outer surface protein A (OspA) as the major surface lipoprotein (Fingerle et al. 1995). 
In response to the blood meal there is rapid multiplication of borrelia, along with increase in 
number there is rapid downregulation of OspA (Schwan et al. 1995). As the borrelia migrates 
from hemocoel to the tick salivary gland it expresses Outer surface protein C as major surface 
protein (De Silva and Fikrig 1997b). This reciprocal expression of OspA and OspC enables the 
mobilization of borrelia from the tick midgut to the salivary gland, and finally into the 





 Viability determination of B. burgdorferi 
The Lyme disease agent, B. burgdorferi can be cultured readily from the EM skin lesions 
(Berger et al. 1992, Mitchell et al. 1993) and often from the concomitant blood samples in BSK-
H medium, thus indicating the presence of viable organisms in the specimen.  
One of the most commonly used methods for differentiating alive and dead spirochetes is 
enumeration of the motile spirochetes in culture medium inoculated with the infected specimen 
under the dark field microscope. The spirochetes which lie still under the dark field microscope 
are considered dead and not taken into account while enumeration.  
The culture based classical methods for detecting the spirochete viability and enumerations have 
limited sensitivity, and are time consuming. Several molecular methods targeting DNA and RNA 
have also been developed for the detection of total as well as viable spirochetes offering higher 
speed, sensitivity, and specificity. However, most attempts to culture the causative organism 
form low burden sites such as synovial fluid (SF) have been negative (Steere et al. 1984, 
Bradley, Johnson, and Goodman 1994) in contrast, Polymerase Chain Reaction (PCR) results are 
often positive at these sites. The presence of viable spirochetes have been quantified by real-time 
PCR and confirmed by in-vitro culture after  7 months of  infection and up to four weeks after 
completion of penicillin treatment (Pahl et al. 1999). PCR targeting spirochete DNA have been 
reported to present some discrepancy with culture results, which could be because of the very 
low spirochete load or the organisms are injured, or dead. Therefore, detection of B. burgdorferi 
DNA may not be a reliable test of active joint infection in Lyme disease. Quantification of B. 
burgdorferi messenger RNA (mRNA), and ribosomal RNA (rRNA) has been a reliable tool for 
differentiation and enumeration of viable spirochetes form the total load identified by DNA 
based assays. Quantitative PCR and RT-PCR based assays are being increasingly used in Lyme 
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disease patients for determination of active infection in patients with persistent arthritis after 
antibiotic therapy.  
 
Figure 1.13. OspA and OspC crossregulation during the infectious cylce of B. burgdorferi. OspA 
is abundantly expressed in tick vector and is rapidly downregulated in response to blood meal in 
order to evade immune detection. OspC expression is increased as B. burgdorferi prepares to 
infect a mammalian host. Figure from (Mulay et al. 2009) 
 
Animal model of Lyme disease 
In general, the animal model for Lyme disease should display disease pathology similar to that of 
human patients. Thus the animals which can be infected with the Lyme disease agent in 
laboratory and show persistent infection with B. burgdorferi along with one or more arthritic 
joints, and involvement of multiple organs with disease symptoms in heart, joint, and skin can be 
considered as the Lyme disease animal model.  
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The first animal model for Lyme disease was introduced by Schaible et al. in 1989 as they found 
inbred mouse strains (C57BL/6 and BALB/c) inoculated with live B. burgdorferi B31 show 
antigen specific T-cell response similar to pathomorphology seen in Lyme disease patients 
(Schaible et al. 1989). Same group also showed that the mice having severe combined 
immundeficiency syndrome (SCID), thus lacking or having abnormal B-cell and T-cell function, 
show progressive polyarthritis and carditis and hence serve even more useful model then 
immunocompetent mice strains for studying Lyme disease (Schaible et al. 1990).  
In addition to mice, many other animal species were proved to be useful in studying Lyme 
disease. In the year 1984, Kornblatt et al. showed that rabbits could contract Lyme disease 
experimentally and show initial signs similar to that in humans (Kornblatt, Steere, and 
Brownstein 1984). The same group showed that dogs can show Lyme arthritis similar to humans 
(Kornblatt, Urband, and Steere 1985). Mursic et al. found that gerbils show multiorgan 
involvement in response to experimental inoculation of B. burgdorferi, and hence can serve as 
suitable Lyme disease model to study the pathogenesis and the extent of organ damage (Preac 
Mursic et al. 1990). Furthermore,  guinea pig was also found to be  useful as a animal model for 
Lyme disease as it showed Lyme disease symptoms upon inoculation (Sonnesyn et al. 1993). 
While most of the rodent and lagomorphs showed Lyme disease infection, none of the animals 
mentioned above show central nervous system (CNS) signs of Lyme disease. Rhesus monkeys 
are the only experimental animals that could develop neuroborreliosis and hence serve as another 
unique Lyme disease animal model (Philipp and Johnson 1994). 
Furthermore, the animals which show infection upon laboratory inoculation, can also be used for 
cultivation of the pathogen in the mammalian host adapted form. The term host adapted form 
represents the antigenic and structural changes taken up by the spirochetes as they transgress 
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from ticks to the mammalian host. The isolated borreliae from infected tissue samples undergo 
changes in antigenic expression as they multiply and adapt to the laboratory culture conditions. 
Thus in order to enable study of spirochetes in the mammalian host adapted form it was essential 
to develop a new animal model which could provide mammalian stimuli and allow pathogen to 
grow in host adapted stage. Such a novel model was developed by Akins et al. in year 1998, this 
model involved implantation of lyme disease spirochetes enclosed within the dialysis membrane 
chambers (DMCs) into the peritoneal cavities of sprague dawley rats (Akins et al. 1998). This 
model provided researchers with an opportunity to cultivate sufficient amount of the mammalian 
host adapted Lyme disease spirochetes for the laboratory experimental analysis. Another added 
advantage of this model was possible cultivation of noninfectious borrelia mutant variants in the 
mammalian host environment, as DMC protects spirochetes from the host immune system. The 
spirochetes in DMC adapt in response to the physiological stimuli provided in the peritoneum of 
rats and express virulence determinants which are essential for the disease pathogenesis (Akins 
et al. 1998). The detailed use and procedure for the DMC technique has been provided in the 
materials and methods section of chapter 2. Hence, the role of Lyme disease animal model is 
extended from serving as a disease simulator to cultivator of B. burgdorferi in host adapted form. 
Molecular regulation of osp in Borrelia burgdorferi  
The deliberate expression and repression of osps in B. burgdorferi is enabled by an intricate 
molecular regulatory system. Though the genome of B. burgdorferi has been sequenced 
completely by Fraser et al. in 1997, the underlying molecular regulation pathways for 
coordinated osp expression is still not completely understood. B. burgdorferi has unique genomic 
features (Figure1.14), including a linear chromosome of about one megabasepair, 12 linear and 9 
circular plasmids, and each plasmid exists as a single copy per chromosome (Fraser et al. 1997, 
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Casjens 2000, Stewart et al. 2005). While there are no genes for cellular biosynthetic reactions in 
borrelial genome, the function of a large number of predicted coding sequence is yet to be 
understood (Casjens 2000). The outer surface proteins are encoded in the borrelial plasmids, thus 
the plasmids basically carry virulence related genes in B. burgdorferi (Stewart et al. 2005).  
The molecular regulatory machinery in borrelia differs considerably from other bacteria, as very 
few homologous regulatory proteins are present (Samuels 2011). B. burgdorferi has three RNA 
polymerase sigma factors: RpoD, RpoN, and RpoS. While RpoD is a major sigma factor, 
regulating most of the house keeping genes, RpoN and RpoS are two alternate sigma factors. 
RpoN and RpoS form a regulatory pathway in which transcription of rpoS is controlled by RpoN 
(Ouyang, Blevins, and Norgard 2008). RpoN binds to the consensus promoter region of rpoS and 
enables further RpoS regulated gene expression (Ouyang, Blevins, and Norgard 2008).  The 
RpoN mediated rpoS expression has been found to be dependent on enhancer binding protein 
and two component regulatory system response regulator: Rrp2 (Ouyang, Blevins, and Norgard 
2008). Thus the RpoN-RpoS pathway can be called Rrp2-RpoN-RpoS pathway. Further studies 
found that Rrp2 is activated by acetyl phosphate a phosphate donor (Xu et al. 2010).  
The RpoN-RpoS regulatory pathway has been found to up-regulate several virulence factors, 
most of these are essential for borrelial adaptation within the mammalian host (Yang et al. 2005). 
The known RpoS regulated crucial virulence factors include outer surface lipoproteins: OspC, 
Decorin binding protein A (DbpA) and Decorin binding protein B (DbpB) (Yang et al. 2005). 
The rpoS mutant fails to downregulate OspA in the mammalian host like conditions. Hence, 





Figure 1.14. Segmented Genome of B. burgdorferi carries numerous plasmids, more than 
reported for any other bacteria. The borrelia plasmids are both linear (lp) and circular (cp), 
named according to their approximate size in kilobase pairs. Above picture was adapted from a 
review by Patricia A.Rosa (Stewart et al. 2005). B. burgdorferi B31 strain is known to carry 22-
23 plasmids (Stewart et al. 2005, Fraser et al. 1997, Hinnebusch and Barbour 1992). The 
plasmids depicted in red required either for maintaining infectivity or persistence of B. 
burgdorferi in tick vector. 
 
Unlike other bacteria, RpoS in B. burgdorferi is critical for expression of virulence genes rather 
than only in general stress response (Caimano et al. 2007). Also, B. burgdorferi lacking rpoS fail 
to produce infection in mouse (Xu et al. 2012). Once the tick vector takes up blood meal, RpoS 
is generated and is continuously expressed throughout the borrelial adaptation within the 
mammalian host (Banik et al. 2011). Thus in conclusion, RpoS is required by borrelia for 
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initiating and maintaining infection in the mammalian host (Banik et al. 2011). However, recent 
studies by contemporary research groups have found another regulator called BosR, required for 
transcription of rpoS B. burgdorferi (Ohnishi, Piesman, and de Silva 2001, Hyde et al. 2009, 
Ouyang et al. 2009). 
Due to its preconcieved role in oxidative stress response, the borrelial protein called BB0647 was 
renamed as B. burgdorferi oxidative stress regulator or BosR (Hyde et al. 2009). However, the 
role of BosR as a borrelial oxidative stress response protein has not been established yet. BosR 
mutant successfully colonize the tick vector but fails to establish infection in lab mice. Therefore, 
BosR is considered essential for causing infection in a mammalian host (Hyde et al. 2009). BosR 
is regarded as the master regulator of RpoN-RpoS regulatory pathway acting like a DNA binding 
protein which binds directly on the rpoS gene (Samuels and Radolf 2009, Ouyang, Deka, and 
Norgard 2011). Thus, BosR acts as a positive transcription activator and plays additional 
regulatory role (Ouyang, Deka, and Norgard 2011). 
Our study shows that bosR mutants fail to repress OspA and OspD in mammalian host 
environment. OspA and OspD both are outer surface lipoproteins in borrelia primarily expressed 
within the tick vector and not required for the infection in the mammalian host (Yang, Pal et al. 
2004, Xin Li et al 2007). Though RpoD is known to regulate expression of ospA within the tick 
vector, the mechanism causing its repression in response to blood meal is still not known. Thus 
the major regulatory role of BosR within the mammalian host is undisputed but remains 





Statement of the problem 
Lyme disease still remains the most commonly reported vector born disease in USA. Even 
though the genome of Borrelia burgdorferi has been completely sequenced (Fraser et al. 1997), 
successful strategies to check the transmission are yet to be developed.  
The knowledge accumulated since discovery of Lyme disease is enough to yield a cohesive 
picture of cellular and molecular events within the enzootic cycle of B. burgdorferi. As the 
lipoproteins form an interface between inside and outside environment for borrelia, the delicate 
balance of outer surface proteins play a central role in its survival (De Silva and Fikrig 1997b, 
Schwan et al. 1995, Xu, McShan, and Liang 2008). The outer surface lipoproteins play a 
collective role in adaptation of B. burgdorferi within the Ixodes tick vector and a mammalian 
host (Xu, McShan, and Liang 2008), however, the survival strategies adopted by the Lyme 
disease spirochetes are not completely understood. 
 The sophisticated regulation of the different surface lipoproteins by borrelia relies on complex 
regulatory mechanisms. Though, borrelia has limited metabolic pathways as it evolved to 
parasitize nutrients from its hosts, the molecular regulatory mechanisms are impressively 
complex and hard to unravel (Fraser et al. 1997). The knowledge of the complex regulatory 
pathways involving limited regulatory factors is still incomplete and is an open field for research. 
The studies revealing new mechanisms of borrelial gene control are crucial to develop new 
strategies to interrupt the spirochete’s life cycle and curb the emerging Lyme disease.  
The outer surface lipoprotein A is abundantly expressed on the surface of B. burgdorferi as it 
lays dormant within tick midgut, however there is rapid downregulation of this protein in 
response to blood meal (Schwan et al. 1995). The vigorous downregulation of OspA is 
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coordinated with upregulation of OspC (Schwan et al. 1995, Schwan and Piesman 2000). This 
reciprocal expression of OspC and OspA is responsible for exit and transmission of borrelia from 
the invertebrate tick vector to a mammalian host (Schwan et al. 1995). The 2010 publication by 
Xu et al. reported a regulatory structure consisting of two sequences flanking the ospA promoter: 
cisI and cisII, these two sequences provide B. burgdorferi with molecular mechanism to quickly 
downregulate or upregulate OspA in response to changes in external environment. However, the 
factors binding these sequences in response to specific environmental stimuli has not been 
identified yet. As the downregulation of OspA is important for survival of B. burgdorferi within 
the mammalian host, identification of underlying molecular mechanism may yield new strategies 
to prevent transmission of Lyme disease (Strother et al. 2007, de Silva et al. 1997). 
The homeostasis on the outer membrane layer of B. burgdorferi is exemplified by several studies 
(Battisti et al. 2008, He et al. 2008, Pal et al. 2004). Crossregulation of OspA and OspC is one 
classic well studied homeostatic expression, as it is central to establishment of the Lyme disease 
and maintenance of the spirochete in enzootic life cycle (Schwan and Piesman 2000, Schwan et 
al. 1995).  
Goal, objectives, and hypothesis 
Goal 
The overall goal of this dissertation is to add to the current knowledge of gene regulation in the 
Lyme disease agent and highlight the homeostatic maintenance of the surface lipoproteins on the 






 The specific objectives and hypothesis of the study are listed below: 
1. To confirm the repression of OspA in bosR mutant and investigate if this repression is 
directly mediated by BosR mediated or indirectly mediated by RpoS. 
2. To find out specific region of ospA operon involved in BosR mediated repression. 
3. To study osp expression in ospA mutant and identify the other surface lipoproteins that are 
involved in maintaining the homeostasis of the outer surface lipoprotein layer in B. 
burgdorferi.  
Hypothesis  
The hypothesis underlying the above mentioned objectives can be stated as following: 
1. BosR is the repressor protein responsible for downregulation of OspA by direct action on 
ospA operon. 
2. The outer surface lipoprotein layer is in a state of homeostasis and loss of a dominant osp 
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DIRECT ROLE OF BORRELIA BURGDORFERI OXIDATIVE 
STRESS REGULATOR IN DOWNREGULATION OF OUTER 
SURFACE PROTEIN A 1 
 
Introduction 
The enzootic infection cycle of B. burgdorferi has two phases: the tick phase and the mammalian 
phase. Each phase requires distinct physiological adaptations. Rapid adaptation in response to 
changing environmental signals by differential gene expression is the key survival strategy used 
by B. burgdorferi (Samuels 2011, Radolf et al. 2012). Most of the differentially expressed genes 
encode for the outer surface lipoproteins (Fraser et al. 1997). Thus, different outer surface 
proteins (osp) are expressed in the tick and mammalian phase (Barbour, Tessier, and Hayes 
1984, Pollack, Telford, and Spielman 1993). A prototypical example of the phase differential 
expression of the surface lipoproteins can be seen in B. burgdorferi as it prepares to infect the 
mammalian host. This involves downregulation of the dominant tick phase osp, OspA, and 
upregulation of the mammalian phase osp, OspC (Schwan et al. 1995, Schwan and Piesman 
2000).  
The maintenance of coordinated outer surface lipoproteins requires intricate regulatory 
mechanisms. B. burgdorferi has a small genome, which encodes very few transcription 
regulators. Its only two known alternate sigma factors, RpoN (σN) and RpoS (σs), form a key 
regulatory cascade. In this regulatory pathway, rpoS depends on RpoN for transcription 
activation (Studholme and Buck 2000). Recent studies have added Rrp2 as the response regulator 
protein controlling activation of RpoN (Yang et al., 2003).  
                                                          
1 A section (all materials pertaining to figures 2.4, 2.5, 2.6, & 2.7) of this chapter previously appeared as part of 
publication: (Wang et al. 2013); it is reprinted with permission of wiley & sons. See the permission letter in 
Appendix A & B 
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The most recent addition to the unique molecular regulators of B. burgdorferi is BB0647. It was 
initially known as borrelial Fur (Ferric uptake response) regulator protein, and is currently more 
well accepted as BosR (Borrelia oxidative stress response Regulator,) due to its shared homology 
with PerR protein (oxidative stress response repressor in Bacillus subtillis) (Hantke 1981, Bagg 
and Neilands 1987).  
Boylan et al. showed BosR to be a transcriptional activator in 2003. They determined that BosR 
binds in-vitro to the upstream region of dps/napA and activates it.2 Furthermore, a 2009 study 
indicated that BosR may function as a universal repressor and activator in B. burgdorferi 
(Ouyang et al. 2009). The same study also showed that BosR is essential for causing infection in 
the mammalian host, but not for persistence in the Ixodes tick vector (Ouyang et al. 2009). While 
Ouyang et al. showed that loss of bosR also resulted in loss of expression of OspC and DbpA, a 
seminal study by J. A Hyde et al. showed that this loss was due to the absence of RpoS (Hyde et 
al. 2009, Ouyang et al. 2009). Thus, the role of BosR in RpoN-RpoS pathway was established as 
a transcriptional activator, with a more recent 2011 study showing that BosR binds directly to the 
upstream regulatory sequence of rpoS to effect its activation (Ouyang, Deka, and Norgard 2011). 
RpoS is required for OspC up- and OspA downregulation, respectively (Caimano et al. 2005, 
Yang et al. 2005); thus, BosR is considered a regulator protein that indirectly controls the 
crossregulation of OspC and OspA in B. burgdorferi.  
However, the studies before identification of BosR indicated that an unidentified 23kDa 
repressor protein directly binds the ospA promoter, and therefore, may govern the OspA 
downregulation (Margolis and Samuels 1995). Additionally, some recent studies have predicted 
indirect RpoS mediated repression of ospA transcription via “a trans-acting DNA binding 
                                                          




protein,” (Caimano et al. 2005, Caimano et al. 2007). Furthermore, recent studies have shown 
that BosR is a 20 kDa DNA-binding protein required for the activation of the RpoS (Caimano et 
al. 2007), which has prompted investigation of BosR as a plausible repressor protein for OspA. 
The present study investigates the possible BosR mediated direct repression of OspA. Also, due 
to known similar expression pattern in enzootic cycle of B. burgdorferi, OspD is also 
investigated together with OspA repression in this study (Stewart et al. 2008). 
The Outer surface proteins (Osps) A and B are encoded by a 2-gene operon (Fingerle et al. 
2007). The expression of the ospA operon is driven by a (RpoD) σ70-dependent promoter 
(Crother et al. 2004).  B. burgdorferi cannot turn off this housekeeping σ factor in pursuit of the 
rapid turnoff of the ospA operon. To do so would likely be lethal to B. burgdorferi. A 1999 
publication by Sohaskey et al. suggested involvement of the T-rich region immediately upstream 
of ospA promoter in regulation of ospA (Figure 2.1). A 2010 study in our lab identified two 
regulatory elements: cisI and cisII, flanking the ospA promoter (Figure 2.1). In this study, both 
these sequences were demonstrated to be required for ospA repression during the mammalian 
infection. Thus, these sequences were demonstrated to equip B. burgdorferi with a molecular 
mechanism for rapid adaptation within the distinct environments during its enzootic cycle 
(Barbour et al. 1986). The successful identification of two regulatory sequences, namely cisI and 
cisII, indicates the existence of a repressor(s), which should bind the two elements and shut off 
the ospA expression during the murine infection (Raetz and Whitfield 2002).  
The current study first shows that BosR bound both cisI and cisII, and then demonstrates that 
increased BosR expression executed a complete switch off of OspA on the borrelial surface. The 
current study interestingly demonstrates that one of the two putative BosR-binding sites 
associated with the ospA operon is completely included within the previously identified cisII 
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regulatory sequence (Labandeira-Rey, Seshu, and Skare 2003), while the second is partially 
overlapped with the -10 region of the promoter (Grimm et al. 2004). 
As an important regulator, BosR has a demonstrated function: it binds the rpoS promoter region 
and positively regulates the alternative σ factor, which, in turn, upregulates a number of osps, 
including OspC and DbpBA (Sears et al. 1991, Wang et al. 2013, Ouyang et al. 2009).  Although 
in vitro cultured B. burgdorferi doesn’t produce BosR during its early growth phase, once grown 
to late log phase, the pathogen dramatically upregulates the regulator. However, this dramatic 
BosR upregulation has been unable to associate with OspA downregulation, seriously 
challenging the notion that BosR, in addition to the identified function described above, may also 
function as a repressor of the ospA operon. The current study demonstrated that BosR binds both 
previously identified regulatory elements of the ospA operon. Furthermore, the study showed that 
increasing expression of BosR can completely turn the operon off when other major osps, such 
as OspC, DbpA and DbpB, were constitutively expressed. Thus, the current study adds a new 
important role of BosR as a repressor protein of ospA operon. 
Material and methods 
 
Growth conditions and harvest of B. burgdorferi 
Borrelia burgdorferi was grown in 40 ml of Barbour-Stoenner-Kelly H (BSK) complete media 
in 50 ml Falcon tubes at 33°C (5% CO2) to about 108cell/ml. Cells were then harvested by 
centrifugation at 3711x g for 20 min at 4°C. The bacterial pellet was washed three times by 
suspended in 40 ml cold HN (10 mM HEPES, 50 mM NaCl, pH 8.0) and centrifuged. 
Supernatant were removed, pellet was further used to SDS-PAGE or 2-DE analysis or stored at -
80˚C for future use. 
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Strains used for this study 
The B. burgdorferi strains  constructed previously from B. burgdorferi type strain B31 by 
Ouyang et al., 2009, and  kindly provided by M.V. Norgard ( University of Texas Southwestern 
Medical Center)  were used (Ouyang et al. 2009). Mutant strains used included bosR lacking B. 
burgdorferi B31, and bosR complemented strain. 
Construction of pIBM-rpoSin, pME22-bosR’ and pME22-C’B’A’-bosR’ 
 As diagrammed in figure.3.2 A , to construct pIBM-bosRin, a 554-bp DNA fragment covering 
the entire coding region of the bosR gene was amplified by using primers P1F and P1R (Table 
3.1) and DNA template extracted from B. burgdorferi B31.  The resultant PCR product was 
purified, digested with NcoI and XhoI, repurified and cloned into pIBM, which was created in a 
previous study (Xu et al. 2012), and pre-digested with the same enzymes.  
To construct pME22-bosR’, a plasmid that conferred constitutive BosR expression, a 597-bp 
DNA fragment containing the entire coding sequence of the bosR gene was amplified using 
primers P2F and P2R (Table 2.1) and DNA template purified from B. burgdorferi B31.  The 
resultant amplicon was purified, digested with BspHI and BamHI, repurified and cloned into 
pME22, which was created in an earlier study(Shi et al. 2008), and pre-digested with NcoI and 





Figure 2.1 Potential regulatory sequences upstream of the coding region of the ospA operon, including a pair of direct repeats, DR1 
and DR2 (labelled with long arrows), a T-rich region (underlined with a solid line), and a sequence between the”10 region and the 
start codon ATG (underlined with a dotted line). The ”35 and ”10 regions, putative ribosome-binding site (RBS), start codon ATG, 
and stop codon TAA (all in bold type) are indicated. The +1 marks thepreviously identified transcriptional initiation site (Jonsson et 




To construct pME22-C’B’A’-bosR’, a plasmid that was able to provide constitutive BosR, OspC, 
DbpA and DbpB expression simultaneously, two plasmids, pME22-bosR’ and pME22-C’B’A’ 
were used.  The plasmid pME22-C’B’A’ was constructed in an earlier study (Grimm et al. 2004).  
A 917-bp DNA fragment covering the promoterless bosR gene fused with the flaB promoter was 
amplified from pME22-bosR with use of primers P3F and P3R (Figure 2.3C; Table 2.1).   A 
10,059-bp DNA fragment harboring the promoterless ospC, dbpB and dbpA fused with the same 
flaB promoter was amplified from pME22-C’B’A’ using primers P4F and P4R (Figure 2.3C; 
Table 2.1).  The resultant PCR products were pooled, purified, digested with NheI and PstI, and 
ligated to complete construction of pME22-C’B’A’-bosR’.   
Table 2.1: Primers used in this study 
Primer   Sequences (5’ to 3’) a                                                                     
P1F AAATTCATGCCATGGACGACAACATAATAGACG 
P1R      TTTCCGCTCGAGTCATAAAGTGATTTCCTTGTTCTC 
P2F AAATCATGAACGACAACATAATAGACGTACATTCC 
P2R  AAAGGATCCACCAGTATTAAGAGTAATAAGAATATAAG 
P3F  AAAGCTAGCAGGAAACAGCTATGACCATGATTAC 
P3R  TGCCAAGCTTGCATGCCTGCAG 
P4F  GACCTGCAGGCATGCAAGCTTGG 
P4R  AAAGCTAGCGTCTTGATTATCGGGCGAAGAG 
P5F  TAATTCCATATGAACGACAACATAATAGACG 
P5R  TTTCCGCTCGAGTAAAGTGATTTCCTTGTTCTC 
aThe underlined sequences are restriction enzyme sites: a BamHI sit (P2R), a BspHI site (P2F), a 
NdeI site (P5F), a NcoI site (P1F), NheI sites (P3F and P4R), PstI sites (P3R and P4F), and XhoI 






Generation of transformants 
The rpoS mutant, ΔrpoS, which was generated in our previous study (Grimm et al. 2004, Xu et 
al. 2012), was grown to late logarithmic (log) phase in Barbour-Stoenner-Kelly H (BSK-H) 
complete medium (Sigma).  Spirochetes were harvested from approximately 40 ml of culture and 
transformed with pIBM-bosRin, pME22-bosR’ or pME22-C’B’A’-bosR’ as described previously 
(Xu et al. 2005).  Transformants were identified by PCR using a primer pair specific for either 
streptomycin or kanamycin cassette and their plasmid content was analyzed as described 
previously (Xu et al. 2005).  
Growth rate estimation 
The spirochete culture was grown at 33°C to late log phase (approximately 108 cells/ml) in BSK-
H complete medium and diluted to 105 cells/ml with the medium.  A total of fifteen 1.3-ml 
aliquots were prepared and IPTG was then added to final concentrations at 0, 0.02, 0.05, 0.10 
and 0.20 mM.  Each inducer concentration was in triplicate.  All aliquots were incubated at 33oC 
and cell numbers were counted daily for 10 days.  Either the parental clone 13A or the 
transformant ΔrpoS/ΔrpoS was used as a control. 
Host adaption of spirochaetes in DMCs 
Mammalian host adapted spirochetes were prepared using dialysis membrane chambers (DMCs) 
implanted intraperitonealy in Sprague Dawley as described by Akins previously (Akins et al. 
1998). The rats used were were 6-8 weeks old and obtained from Division of Laboratory Animal 
Medicine at Louisiana State University, Baton Rouge. All animal procedures described were 




Figure 2.2. Construction of pIBM-bosRin, pME22-bosR’ and pME22-C’B’A’-bosR’.  (A) To 
construct pIBM-bosRin, a 554-bp DNA fragment covering the entire coding region of the bosR 
gene was amplified.  The resultant PCR product was cloned into pIBM.  (B) To construct 
pME22-bosR’, a 597-bp DNA fragment containing the entire coding sequence of the bosR gene 
was amplified and cloned into pME22.  (C) To construct pME22-C’B’A-bosR’, a 917-bp DNA 
fragment covering the promoterless bosR gene fused with the flaB promoter was amplified from 
pME22-bosR’.   A 10,059-bp DNA fragment harboring the promoterless ospC, dbpB and dbpA 
fused with the flaB promoter was amplified from pME22-C’B’A’.  The resultant PCR products 





The Spectra/Por® 6 Standard Grade Regenerated Cellulose dialysis membrane with molecular 
weight cut-off of 8 kDa (Spectrum Laboratories, Rancho Dominguez, CA) was used for making 
the dialysis membrane chambers. The dialysis membrane was treated with 5 mM EDTA to 
remove any heavy metal impurities and was subsequently autoclaved.  The dialysis membrane 
chambers were filled with 5 ml of 103 spirochaetes per ml of spirochete containing BSK-H 
complete media. The spirochetes were first cultured to late log phase and then diluted to 103/ ml. 
Using standard aseptic techniques, sterile DMC was implanted into the peritoneum of rat, after 4 
weeks of adaptation in DMCs, approximately 5 × 107 of the bosR mutant and 2 × 107 of the 
complemented bosR mutant were recovered and subjected to immunoblot and q RT-PCR 
analyses as described below. 
Immunoblot and Coomassie analysis 
Spirochetes were harvested from culture (both DMC & BSK-H) and pelleted by centrifugation at 
5,000×g at 4oC.  The spirochetes were then suspended in Laemmli buffer (Laemmli 1970) at 
spirochetes to 2 × 105 spirochaete cells/μl. The sample was incubated at 100°C for 10 min. SDS-
PAGE was run using 5 μl of each sample. The SDS run samples were  transferred to 
nitrocellulose membrane and were incubated with a mixture of FlaB mAb and mouse anti-BosR 
sera or OspC mAb alone as described in our previous study (Xu et al. 2006) or pooled sera 
(antibodies for FlaB, BosR, OspC, OspA, or OspD) from mice  infected with B. burgdorferi B31 
strain via tick infestation. Immunoblot reaction was performed using goat α-mouse IgG-
horseradish peroxidase conjugate (Kirkegaard & Perry Laboratories) at a 1:10000 dilution and 
developed using SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific) and 
captured on X-ray films. For protein analysis, proteins separated on SDS-PAGE gels were 
directly stained with Coomassie Brilliant Blue G-250 (Amresco, Inc., Solon, and OH). 
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Quantitative RT-PCR and PCR 
 
Total RNA was extracted from harvested spirochaetes using TRIZOL reagent (Life 
Technologies) and treated with RNase-free DNase I (Roche) for complete digestion of possible 
DNA contamination. In order to achieve highest purity RNA preparation was purified using 
RNeasy mini spin column (Qiagen) following the manufacturers’ instructions. 
 For q RT-PCR analysis, RNA was first reverse transcribed into cDNA using Superscript™ III 
reverse transcriptase (Life Technologies) and random hexamers. A mock reaction without 
reverse transcription was also performed to ensure that preparation is DNA free. A standard 
curve was generated by using a 10-fold dilutions of genomic DNA from known concentrations 
B. burgdorferi and a linear standard curve was achieved. These standards were assayed in 
triplicates to generate a linear calculation curve, which was used to convert the threshold cycle 
(Ct) values into gene copy numbers of the test samples. Quantitative PCR was performed in 96-
well plates using SYBR® green PCR master mix (Applied Biosystems) and primers targeting 
specific sequences (Table 2.1) using ABI 9500 thermal cycler and negative control in duplicates 
were also added to the plate (Grimm et al. 2004), (Liang et al. 2004).   
Expression and purification of recombinant BosR 
The entire bosR-coding region was amplified from genomic DNA of B. burgdorferi B31 using 
primers P5F and P5R (Table 2.1).  Resultant PCR product was digested, purified and cloned into 
pET-23a vector (EMD Chemicals Inc., Darmstadt, Germany), generating a construct that 
contained the bosR-coding region fused with a C-terminal His6 tag.  One Shot® 
BL21(DE3)pLysS Chemically Competent E. coli cells (Life Technologies, Grand Island, NY) 
were transformed with the construct and induced with 1.0 mM isopropyl-beta-D-
thiogalactopyranoside  (IPTG) (Sigma Chemical Co., St. Louis, MO).   
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Recombinant BosR was affinity-purified using HiTrap Chelating HP following the 
manufacturer's instruction (GE Healthcare Bio- Sciences, Pittsburgh, PA).  Protein concentration 
were measured using Quick Start™ Bradford Dye Reagent following the manufacturer’s 
instructions (Bio-Rad Laboratories, Hercules, CA).  
Table 2.2: Oligos used for quantitative PCR assay 
Name  Sequence (5’ – 3’)  
flab + 441 Forward AGCTGAAGAGCTTGGAATGC 
flab + 543 Reverse  TTGGTTTGCTCCAACATGAA 
bosR + 41 Forward  AAGTCGGCATTACAAACGAT 
bosR +153 Reverse  TTTTGGGTTTGATGCTATGTAT 
ospA +166 Forward  GCAACAGTAGACAAGCTTGAGC 
ospA +295 Reverse  GTGTGGTTTGACCTAGATCGTCA 
ospC +12 Forward TACATTAAGTGCAATATTAATGACT 
ospC +125 Reverse  AGATTAGGCCCTTTAACAGA 
rpoS +108 Forward   AGGCAATGCAAAAGCAAAAA 
rpoS +232 Reverse  ATCCCAAGTTGCCTTCTTGA 
 
Electrophoretic mobility shift assay 
To date, BosR has been shown to recognize sequences upstream of at least three other genes, 
rpoS, bosR itself, and the gene encoding neutrophil activating protein A (NapA) (Liang et al. 
2002, Katona et al. 2004, Ouyang, Deka, and Norgard 2011). Primers (Table 2.2) spanning 330 
bps upstream and 20 bps downstream of the start of the ospA gene and 231 bps upstream and 68 
bps downstream of the start of the ospD gene were designed (Table 2.2) and single band PCR 
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products were used as probes for EMSA. Primers targeting upstream region of B. burgdorferi 
genes ospA, ospD, rpoS, bicA, bosR, and ospC were designed and targeted regions were 
amplified from B. burgdorferi type strain B31 using iProof DNA polymerase (Bio-Rad). Primers 
labeled with biotin at 5′-end were used to generate biotinylated PCR fragments, which were then 
purified on a 1.5% SeaPlaque (Lonza) agarose gel using the QIAquick gel extraction kit 
(Qiagen) and DNA concentration was determined by absorbance at 260 nm and used as a probe 
in EMSA. Each strand of the probes CisI, CisII, and IRs (Figure 2.3) was synthesized, 
respectively, by Integrated DNA Technologies, Inc. (Coralville, Iowa).  One strand of each 
complementary pair was incorporated with 5’ Digoxigenin during synthesis.  Complementary 
strands were allowed to anneal to form a double-stranded probe.   
Both the His6-tagged and the tag-free BosR were affinity-purified from E. coli as a soluble 
recombinant protein and found to be active, His6-tagged BosR was used for EMSA assays.  
For the density dependent competiton assay (Figure 2.6), the probes (1 nM) were incubated at 
room temperature for 10 min with 5-, 10-, 20-, 40-, 80-, 160-, 320- or 640-fold molar excess of 
BosR dimer in 20 μl reactions containing 10 mM Tris (pH 7.5), 50 mM KCl, 1 mM DTT, 5% 
glycerol, 50 μg /ml salmon sperm DNA, and 100 μg/ ml of BSA. Annealing pairs of 
complementary oligos were used as double-stranded competitor oligos (Table 2.2) in equi-molar 
ratio. For competitor EMSA, BosR (320 nM of dimer) was incubated with 2-, 4-, 8-, or 16-fold 
molar excess of a competitor prior to incubation with a probe (1 nM) and the binding reactions 
were separated by electrophoresis on 6% polyacrylamide gels prepared in 0.5× TBE (Bio-Rad; 
45 mM Tris, pH 8.3, 45 mM boric acid, 1 mM EDTA) and then transferred to nylon membranes. 
The biotin signal was detected using Light Shift chemiluminescent EMSA kit (Thermo 




Figure 2.3. Diagram of cisI, cisII and putative BosR-binding sites of the ospA operon and three 
probe sequences used in the study. (A) The location of cisI, cisII and putative BosR-binding sites 
and the sequences of cisI and cisII probes. The regulatory sequences upstream of the coding 
region of the ospA operon include cisI and cisII (both in bold) and two putative BosR-binding 
sites (italic). One putative site is overlapped with the -10 region and the other is contained within 
cisII. The -35 and -10 regions of the promoter, transcriptional initiation site, and start codon 
ATG are underlined. The sequences of cisI and cisII probes are marked with brackets.  (B) The 
IRs were identified as the ospC operator in a previous study (Xu, McShan, and Liang 2007), and 
used as a control probe. The sequence of the probe is marked with a bracket 
 
The binding assay (Figure 2.8) reaction volume was set in a 20 μl, in which 1.0 nM DNA probe 
was allowed to bind 400 nM of recombinant BosR at room temperature for 10 min. The binding 
buffer contained 50μg/ml salmon sperm DNA, 100μg/ml BSA, 1.0 mM DTT, 50 mM KCl, 10 
mM Tris (pH, 7.5) and 5% glycerol.  In competition assay, 10 nM DNA competitor was first 
added to a reaction volume of 20 μl and allowed to interact with 400 nM of recombinant BosR at 
room temperature for 10 min before 1.0 nM DNA probe was supplemented and incubated for an 
additional 10 min.  Resultant mixtures were separated by electrophoresis on 10% polyacrylamide 
gels prepared with 0.5× TBE buffer.  Separated DNA was transferred to a nylon membrane and 
probed using DIG High Prime DNA Labeling and Detection Starter Kit I as per the 




Table 2.3 Primers used to generate probes and competitive oligos for Electrophoretic mobility 
shift assay (EMSA) 
 
Name 5’-Label Sequence (5’ – 3’) 
53% G+C For Biotin CTATTCTGGACTACCTGCTGA 
53% G+C Rev  CAATGTCTTTGCGTTTCGCTT 
ospD -231 For Biotin AGCATCATTAAACATCCTTTCAATA CTCA 
ospD +68 Rev Biotin ATCATGAACACAAGATATTGAGAGCAAT 
Rnd Rev  CCCAGTCATCTTCATTGACTCATACCC 
Fur For  GGGAAATGATAATAATTATCATTTGGG 
Fur Rev  CCCAAATGATAATTATTATCATTTCCC 
Per For  GGGAATTTATAATTATTATAAATTGGG 
Per Rev  CCCAATTTATAATAATTATAAATTCCC 
DR For  GGGTAAATTAAATTAAATTAAATGGG 
DR Rev  CCCATTTAATTTAATTTAATTTACCC 
RndAT Rev  CCCTTTATTTTAAATATATTATACCCTA 
Per/7-0-7 For  GGGAATTTATAATATTATAAATTGGG 
Per/7-1-7 Rev  CCCAATTTATAATATTATAAATTCCC 
Per/7-2-7 For  GGGAATTTATAATTTATTATAAATTGGG 
Per/7-2-7 Rev  CCCAATTTATAATAAATTATAAATTCCC 
Rnd For  GGGTATGAGTCAATGAAGATGACTGGG 
RndAT For  GGGTATAATATATTTAAAATAAAGGGTA 
ospA -330 For Biotin ATCAAGACAAACATTGCTGCTTTAA 
ospA +20 Rev Biotin CCCAATAAATATTTTTTCATAATATATTCTCCTT 
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Table 2.3 Continued 
Name 5’-Label Sequence (5’ – 3’) 
rpoS -277 For Biotin CTTGTGTTCTCTTACTGATTTTAAATATATGTTT 
rpoS +60 Rev Biotin TGCTAAACGGAGGCCAAGTA 
bosR -183 For Biotin TGTCGTTCATATGATTATACCTTTTTTGT 
bosR +10 Rev Biotin CTGAATTCAAAAATAAAAAATTTAATTTTTTATACT 
bicA -170 For Biotin TCTTCTTTTGTATCTATTTTATGCATT GT 
bicA +159 Rev Biotin AGTTTTTTTGTGAATAACAAAGAAATTGGT 
Rnd Rev FAM CCCAGTCATCTTCATTGACTCATACCC 
RndAT Rev FAM CCCTTTATTTTAAATATATTATACCC 
ospA -60 For FAM TAATCTTATAATATAATTATACTT 
ospA -37 Rev  AAGTATAATTATATTATAAGATTA 
ospD -85 For FAM ATAATTGATATTAAAATATAATTGAT 
ospD -60 Rev  ATCAATTATATTTTAATATCAATTAT 
ospA -330 For FAM ATCAAGACAAACATTGCTGCTTTAA 




Repression of OspA and OspD in mammals requires BosR 
 To determine the OspA repression in BosR lacking B. burgdorferi, the bosR mutant and the 
isogenic complemented bosR mutant were cultivated in the DMCs implanted within the rat 
peritoneal cavity. The bosR mutant did not express OspC and several other lipoproteins that are 
expressed in the mammalian host, but the levels of these proteins were restored in the 
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complemented bosR mutant (Figure 2.4). Also OspA and OspD protein levels were different for 
the two variants ,while the bosR complement repressed OspA and OspD expression when 
adapted in DMC just like its parental B31 background (Akins et al. 1998, Brooks et al. 2003) the 
bosR mutant failed to do so (Figure. 2.4). 
Quantification of the immunoblot bands showed that the relative OspA and OspD protein levels 
were 3.8-fold and 3.5-fold higher, respectively, in the bosR mutant than in the complemented 
bosR mutant (after normalization against the FlaB protein level) (Figure 2.5A).  
Quantitative reverse transcription-polymerase chain reaction (q RT-PCR) was performed to 
determine whether these differences at the protein levels could be observed at mRNA.  After 
normalization against the flaB mRNA level, the relative ospA and ospD mRNA levels were 2.7-
fold and 5.5-fold higher, respectively, in the bosR mutant than in the complemented bosR mutant 
(Figure 2.5B). 
The data above clearly shows that absence of BosR causes significant increase in the ospA and 
ospD mRNA levels, which may be responsible for increase in the OspA and OspD protein levels. 
The experimental results shown here suggest that OspA and OspD fail to be repressed in absence 
of BosR. As absence of BosR causes absence of RpoS, these results are consistent with previous 




Figure 2.4. OspA and OspD repression in DMC requires BosR. The bosR mutant (mut.) and the 
complemented bosR mutant (comp.) were cultivated for 4 weeks in DMCs implanted in rat 
peritoneal cavities and immunoblot analyses were performed using pooled sera from mice 
infected with B. burgdorferi type strain B31 through tick infestation (α-B31) as well as 
antibodies specific to FlaB, BosR, OspC, OspA, and OspD. 
 
 
Figure 2.5: BosR dependent down regulation of OspA and OspD DMC: The bosR mutant (mut.) 
and the complemented bosR mutant (comp.) were cultivated for 4 weeks in DMCs implanted in 
rat peritoneal cavities and then subjected to protein and RNA analyses.  (A) Relative protein 
levels of BosR, OspC, OspA, and OspD (after normalization against the FlaB level) in the bosR 
mutant as compared with those in the complemented bosR mutant. Data above is based on 
quantification of the immunoblot results shown in figure 2.4. (B) The mRNA levels of bosR, 
ospC, ospA, and ospD (after normalization against the flaB mRNA level sample) in the bosR 
mutant as relative to their respective levels in the complemented bosR mutant. Data were based 
on triplicate qRT-PCR analysis of the RNA samples obtained from the same DMC-adapted 




The above results indicate indirect role of BosR in downregulation of OspA and OspD. 
However, BosR homology to family of transcriptional regulators (FuR) known to function as 
repressors (Cullen, Haake, and Adler 2004, Fung et al. 1994) and more common role of sigma 
factors like RpoS in transcription activation suggest an alternative explanation for the increased 
ospA and ospD mRNA levels, which is, BosR may be repressing the ospA and ospD transcription 
direclty by interacting with the promoter regions . 
BosR binds directly to sequences upstream of the ospA operon and the ospD gene 
BosR-binding to PrpoS, PbosR, and PbicA was compared to PospAB and PospD binding as to date, BosR 
has been shown to recognize sequences upstream of at least three other genes, rpoS, bosR itself, 
and the gene `encoding neutrophil activating protein A (NapA) now called BicA, Borrelia iron- 
and copper-binding protein A (Liang et al. 2002, Katona et al. 2004, Ouyang, Deka, and Norgard 
2011). Sequences upstream of the ospC gene (as it is RpoS regulated) and two unrelated genes 
from Ehrlichia chaffeensis (ech193 and ech818) were included as negative controls in this 
experiment. Weaker but nonetheless dose-dependent BosR binding to PospC, Pech193, and Pech818 
was detected. As BosR did not bind to the synthetic probe that was 53% G+C  probe (PG+C) 
while it did bind to all other probes in this study (which were AT rich)  the minimal BosR  
binding to PospC, Pech193, and Pech818  could be attributed to propensity of BosR to bind AT- rich 
sequences (Figure 2.6A ). Thus conclusively to the EMSA results it can be stated that despite 
having a propensity for AT-rich sequences, BosR binds to sequences upstream of the ospA 
operon and the ospD gene, much more strongly than to the upstream of the ospC gene.  
 The EMSA for dose dependent BosR binding to probes based upon the upstream sequences of 
ospA operon and the ospD gene (PospAB and PospD) demonstrated that BosR readily binds to 




Figure 2.6. BosR directly binds to sequences upstream of the ospA and the ospD genes. BosR 
binding to PospAB, PospD, PrpoS, PbicA, PbosR, PospC, Pech193, Pech818, and P53%G+C was analysed by 
EMSA. Probes (1 nM) were first incubated with BosR (5–640 nM of dimer) and then separated 




Figure 2.7. Relative binding of BosR to PospA and PospD: BosR binding curves for PospAB (closed 
circle), PospD (closed square), PrpoS (closed triangle), PbicA (closed diamond), PbosR (open circle), 
PospC (open square), Pech193 or Pech818 (open triangle), and P53%G+C (open diamond) were generated 
based on quantification of the EMSA data shown in Figure 2.6. Fraction of probe bound by BosR 
in each reaction was calculated by dividing the intensity of all shifted bands (indicated with a 
bracket) with the total intensity of both the shifted bands and the unbound band (indicated with a 
line). In some probes, there were minor isomers (indicated with asterisks) that migrated slower 
and were often not recognized by BosR. These isomers were excluded in the quantitative 
analysis. For clarity, curves for the B. burgdorferi probes were indicated with solid lines, and 






The ospA regulatory sequences, cisI and cisII, bind BosR, albeit cisII shows much stronger 
binding   
Our previous study identified two regulatory sequences, one located upstream of the ospA 
promoter, cisI, and the second between the promoter and the translational start codon,  cisII, 
regulating the downregulation of ospA expression as B. burgdorferi prepares to infect the 
mammalian host (Xu, McShan, and Liang 2010). Also the above results (Figure 2.6) have 
indicated the existence of two putative BosR-binding sites associated with the ospA locus.  One 
of the sites is completely included within cisII and the second covers the entire -10 region of the 
ospA promoter and the first two base pairs of cisII (Figure 2.1 & 2.3).  As the second site of the 
14-bp putative BosR-binding sequence is overlapped with the -10 region, it is impossible to 
entirely remove it without inactivation of the ospA promoter.  For this particular reason, only 2 
bps of this putative binding site were identified as a part of cisII in the previous study (Liang et 
al. 2002). 
The regulatory sequence cisI contains no putative BosR-binding site but showed a critical role in 
repression of ospA transcription during murine infection, albeit it is less effective than cisII in 
this regard (Xu, McShan, and Liang 2010).  To examine if the previously identified regulatory 
elements were able to bind BosR, three 70-bp DNA probes, namely probes cisI, cisII and IRs, 
respectively, were synthesized as diagrammed in figure 2.3  Probe cisI covered the entire cisI 
sequence and additional 14 bps down- and upstream sequences.  Probe cisII included the entire 
cisII sequence and extended upstream to include the -35 region of the ospA promoter.  Probe IRs 
contained the ospC IRs and extended few bps up- and down-stream to make up a total of 70 bps.  
The IRs sequence was previously identified as an operator of the ospC gene and was not 
expected to bind BosR, and thus was chosen as a negative control (Xu, McShan, and Liang 
2007). To minimize nonspecific DNA interaction with BosR, the binding buffer was 
54 
 
supplemented with 50μg/ml salmon sperm DNA.  As shown in figure2.8 the presence of sperm 
DNA completely eliminated the interaction of IRs probe with BosR.  In contrast, the mobility of 
both cisI and cisII probes was completely restrained by BosR, a result that clearly indicates that 
both cisI and cisII are able to effectively bind BosR.   
Excessive BosR expression causes cell death in B. burgdorferi  
To artificially regulate BosR expression, pIBM-bosRin was constructed as illustrated in figure2.2.  
Within the construct, BosR expression was under control of an inducible promoter.  The BosR 
production cannot occur due to the construct in the absence of the inducer IPTG, although the 
native bosR gene may produce BosR as normal.   
 
 
Figure 2.8. Both the regulatory sequences of the ospA operon, cisI and cisII, bind BosR and cisII 
shows stronger binding: The binding buffer contained 50μg/ml salmon sperm DNA.  The ratio of 
a DNA probe and a competitor was set at 1:10 (1.0/10 nM).  Mobility shift analysis was 





The plasmid pIBM-bosRin was easily introduced into ΔrpoS, which was used because any RpoS 
involvement in OspA downregulation was readily ruled out in this way. The plasmid pIBM-
bosRin was also electroporated into 13A, the parental clone of ΔrpoS, as a control. In a single 
transformation experiment with ΔrpoS, five transformants were obtained.  Plasmid analyses led 
to the identification of one clone, namely, ΔrpoS/bosRin, which lost cp9, lp5, lp21, lp25 and lp56 
as ΔrpoS, in addition to lp28-1.  Transformation of 13A led to selection of 7 transformants, one 
of which, namely 13A/bosRin, lost cp9, lp5, lp21, lp25, lp56 and lp28-1 and was chosen for 
further studies.  There had been no evidence that any of the lost plasmids affects gene regulation 
although both lp25 and lp28-1 are critical for murine infection (Xu, McShan, and Liang 2007).  
A recent study reported that increasing RpoS expression causes cell death (Chen at el 2013).  To 
investigate whether high BosR expression is toxic, both ΔrpoS/bosRin and 13A/bosRin were 
grown to early log phase (107 cells/ml) in BSK-H medium and diluted to 105 cells/ml before 
IPTG was added to a final concentrations ranging from 0 to 0.2 mM.  When IPTG reached as 
low as 0.05 mM, ΔrpoS/bosRin growth was affected negatively (Figure 2.9A). When the 
concentration increased to 0.1 mM, growth was essentially arrested within a couple of days after 
induction and all spirochetes eventually died within a week.  Although at lower concentrations 
IPTG did not affect early growth, its presence reduced the stationary cell density.  
13A/bosRin was little less sensitive than ΔrpoS/bosRin to induction with IPTG.  At 0.1 mM, the 
inducer showed little effect on growth (Figure 2.9B).  Even at 0.2 mM, spirochetes continued to 
grow for a couple of days and then started to die and induced spirochetes became uncountable 




Inducing BosR expression leads to dramatic downregulation of OspA 
As shown above, excessive BosR expression caused a lethal consequence to B. burgdorferi.  At 
0.2 mM, IPTG significantly inhibited both ΔrpoS/bosRin and 13A/bosRin shortly after the 
induction and eventually killed them within a week.  This concentration was chosen to 
investigate how induction of BosR influenced OspA expression.   
The ΔrpoS/bosRin and 13A/bosRin spirochetes were grown to 10
7 cells/ml and then IPTG was 
supplemented to 0.2 mM. The IPTG induction was allowed for 3 days before spirochetes were 
harvested and analyzed.  During this time, the spirochete density reached 108 cells/ml, reflecting 
a 3-fold increase. As shown in figure 2.10, as BosR was induced, OspA expression was 
dramatically reduced in ΔrpoS/bosRin. A less prominent effect of induced BosR expression on 
OspA downregulation was observed in 13A/bosRin.   
It should be noted that OspA may be pretty stable in live cells and thus reduction in detected 
protein amount might primarily depend on the dilution effect of cell division.  The total bacterial 
number increased approximately 3 times after induction.  Therefore, reduction in OspA amount 
might not be more than 3-fold even if the transcriptional process could be fully stopped 
immediately upon induction. Moreover, the abundant ospA mRNA accumulated before induction 
would continue to be translated into protein until they were degraded.  
Total RNA was also prepared and analyzed. As shown in figure 2.10 C, induced BosR 
expression led to more than 86% reduction in ospA transcription in ΔrpoS/bosRin and 65% in 
13A/bosRin.  Unlike protein, mRNA is less stable and its level would better reflect the magnitude 





Figure 2.9. Excessive BosR expression causes cell death: (A)  A total of 15 1.3-ml aliquots of 
ΔrpoS/bosRin spirochetes at a density of 10
5 cells/ml were prepared and supplemented with IPTG 
to final concentrations at 0, 0.02, 0.05, 0.10, and 0.20 mM.  Each sample was incubated at 33oC 
and assayed in triplicate. The cell numbers were counted daily for 10 days.  Mean counts 
presented here were calculated from the triplicates of each treatment. The ΔrpoS/rpoS 
spirochetes were used as a control.  (B) The same experimental design was used to examine the 






Figure 2.10. Inducing BosR expression leads to dramatic downregulation of OspA: (A&B). Both 
ΔrpoS/bosRin and 13A/bosRin spirochetes were grown to a density of 10
7 cells/ml and then 
supplemented with IPTG to a final concentrations at of 0 or 0.2 mM.  Induction was allowed for 
3 days. Treated bacteria were harvested and analyzed either by immunoblotting probed with a 
mixture of FlaB mAb and mouse BosR antibodies (A, upper panel) or with OspC mAb alone (A, 
lower panel), or Coomassie staining (B). (C) Total RNA was extracted from induced and 




Although induction led to a dramatic increase in BosR production, OspC expression didn’t 
significantly increase (Figure 2.10), probably because RpoS was also positively regulated by 
other regulators, such as RpoN, small RNAs and Badr (Miller, Karna, and Seshu 2013, Lybecker 
and Samuels 2007, Hubner et al. 2001, Samuels 2011). An unbalanced increase in BosR 
expression might not overwhelm RpoS expression if expression of RpoN was not dramatically 
mobilized. 
Increasing BosR expression completely shutoffs OspA production when constitutive 
expression of other Osps simultaneously occurs 
Increasing BosR expression leads to dramatic downregulation of OspA but is never able to shut 
off expression, even when BosR expression was induced to a toxic level.  To completely 
downregulate OspA with increased BosR, we designed an experiment based on our hypothesis 
that the Osp layer homeostasis of B. burgdorferi overwrites the normal regulatory programs.  In 
other words, as OspA/B are so dominantly expressed osps in cultured spirochetes, B. burgdorferi 
cannot completely downregulate them without dramatically increasing expression of other osps.  
To continue to address the hypothesis, two additional constructs, pBBE22-bosR’ and pBBE22-
C’B’A’-bosR’, were created as shown in figure 2.2 B & C. Within the former, the fused bosR 
gene was designed to express under the control of  flaB promoter, while in the latter, in addition 
to a fused bosR gene, three osp genes, ospC, dbpA and dbpB, were all engineered to transcribe 
under control of a fused flaB promoter.  After the two constructs were introduced into ΔrpoS, 
five and eight transformants were obtained, respectively.  Plasmid analysis led to identification 
of two clones, namely, ΔrpoS/bosR’ and ΔrpoS/C’B’A’-bosR’, which lost cp9, lp5, lp21, lp25 
and lp56 as ΔrpoS, in addition to lp-28-1. As shown in figure 2.11B, a high level of BosR 
expression driven by the fused flaB promoter greatly downregulated OspA but was unable to 
completely shutoff its expression, consistent with the results obtained above with the inducible 
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promoter shown in figure 2.10 B.  Whereas the simultaneous expression of OspC, DbpA and 
DbpB, along with the constitutive BosR production led to successful shutoff of OspA production 
(Figure 2.11B).   
 
Figure 2.11. Increasing BosR expression shuts off OspA production only when other osps, OspC, 
DbpA and DbpB, are constitutively expressed:  The ΔrpoS, ΔrpoS/bosR’ and ΔrpoS/C’B’A’-
bosR’ were grown to early log phase (108 cells/ml), harvested and analyzed either by 






The in-vitro BSK-H cultivated B.burgdorferi shows simultaneous expression of OspA, OspC, 
and OspD. Downregulation of OspA requires mammalian host specific signals, even in nature 
only a part of the spirochetes colonizing tick vector midgut downregulate OspA in response to 
blood meal and migrate to the salivary glands and infect the mammalian host. Thus in order to 
understand the mechanism of OspA downregulation it is very important to provide mammalian 
host environment to B. burgdorferi strains involved in this study. In order to see difference in 
expression of the outer surface lipoprotein layer between bosR mutant and bosR complement 
strain, both were incubated in DMCs implanted in the rat peritoneum (a technique providing 
mammalian physiological signals). Consistent with previous reports, OspC expression was 
absent in host adapted bosR mutant while it was expressed in bosR complement.This further 
confirms the requirement of BosR for OspC expression (Hyde et al. 2009, Ouyang et al. 2009). 
Further, just like the wild type B. burgdorferi B31 adapted in DMC, OspA and OspD were 
downregulated in bosR complement (Akins et al. 1998, Brooks et al. 2003). Based on these 
expression differences for OspC, OspA, and OspD it was confirmed that both bosR mutant and 
bosR complement spirochetes were optimally mammalian host adapted for further analysis. 
Based on the electrophoretic mobility shift assay results, this study demonstrated that BosR 
directly binds to sequences upstream of the ospA and the ospD. This upstream region of ospA 
operon have been shown in a previous 2010 study by our lab to be involved in OspA regulation 
(Xu, McShan, and Liang 2010). The present study indicates that BosR is capable of producing 
repression of OspA by direct binding to its promoter region and hence acts as a repressor for it. 
Until now OspA downregulation has been considered to be regulated by RpoS, as the study by 
Caimano et al. had demonstrated that loss of rpoS in B. burgdorferi also resulted in lack of OspA 
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repression within the mammalian host (Caimano et al. 2007). The requirement of RpoS for 
downregulation of OspA in addition to newly found direct OspA repressor function of BosR 
suggests that, BosR alone is not sufficient for OspA repression. In an unfed tick OspA is the 
most abundantly expressed osp on the borrelia surface. A previous study in our lab showed that 
expression of osps plays an important protective role in maintenance of viability of spirochetes. 
As shown in various studies, the outer surface lipoproteins may be expressed in accordance to a 
certain level of homeostasis of the outer surface. B. burgdorferi mutants have shown 
compensatory upregulation of osps supporting the surface homeostasis theory for example, a 
2008 study by He et al. demonstrated that the deletion of ospA operon in B. burgdorferi lead to 
constitutive activation of Rrp2-RpoN-RpoS pathway and thus constitutive expression of OspC 
(He et al. 2008). However, in a similar study, parental B31 as well ospA mutant did not show 
OspC expression, showing increased level of several other outer surface proteins (Battesti, 
Majdalani, and Gottesman 2011). This study also indicated that OspC was not a unique 
compensatory osp. Another study also reported example of compensatory osp upregulation in B. 
burgdorferi (297 strain) ospC mutant, in which several other lipoproteins were found to be 
upregulated under the RpoS regulon like DbpA, DbpB, and BBK32 (Pal et al. 2004).  
In each of the above mentioned studies, different strains of B. burgdorferi appeared to 
compensate the loss of one or the other lipoprotein with increased expression of other 
lipoproteins. Therefore, it is possible that deficiency of RpoS-mediated outer surface lipoproteins 
cause immense pressure on spirochete to maintain expression of tick phase surface lipoproteins 
(OspA and OspD). Nonetheless, BosR most probably acts as a repressor for ospA. 
 
The lipoprotein nature and dominant expression of OspA makes it highly immunogenic and thus 
elicits a strong mammalian immune response (Barthold et al. 1995, Weis, Ma, and Erdile 1994).  
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Though, the mammalian OspA antibodies may not effectively eliminate B. burgdorferi from host 
tissues but can still prove fatal for spirochetes when acquired by the infected tick vector along 
with blood meal, this may eventually lead to disruption of borrelial enzootic cycle (de Silva et al. 
1996, de Silva et al. 1999). Thus, in order to maintain itself in the natural cycle B. burgdorferi 
must rapidly downregulate OspA and evade immune detection in the mammalian host. The 
present study elucidates the mechanism of OspA downregulation and demonstrates that BosR 
binds the regulatory elements namely cisI and cisII on the ospA operon and shuts down the OspA 
expression on borrelial surface. Hence we can state that BosR functions as a repressor and the 
two regulatory elements, cisI and cisII, serve as operators of the ospA operon. 
A previous study in our lab identified cisI and cisII as the two regulatory sequences flanking 
ospA operon that are required to produce maximum downregulation during murine infection (Xu, 
McShan, and Liang 2010). This study also demonstrated that downregulation mediated by cisII 
was four fold more effective than by cisI (Xu, McShan, and Liang 2010). Hence the findings of 
present study are in congruence with the previous results. It was observed that both cisI and cisII 
elements bind BosR and indeed cisII binding was much stronger than that mediated by cisI. This 
double-operator system, comprised of cisI and cisII sequences, use BosR as a common repressor 
and enables the complete shutoff of ospA operon, and thus provides B. burgdorferi with a 
protective mechanism to hide from host immune system and maintain its enzootic infection 
cycle.  
BosR is required for expression of RpoS, which in turn activates ospC, dbpBA and many other 
osp genes (Hyde et al. 2009, Ouyang et al. 2009, Wang et al. 2013).  The regulator is not 
expressed in early growth phases but is dramatically upregulated in late log phase. There has 
been no significant OspA downregulation observed in cultured spirochetes although BosR 
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expression is considered reaching the highest level in late log phase.  Even in the vector tick’s 
midgut, no more than 50% of the spirochete population downregulate OspA during any period of 
blood meal although most of the remaining population express OspC abundantly, an indication 
that BosR is actively expressed (Purser and Norris 2000).  It is not an easy task to downregulate 
OspA although B. burgdorferi readily shuts off OspA either during mammalian infection or 
while being grown in host-adapted conditions (Barthold et al. 1995, Akins et al. 1998).  These 
previous observations foretold what we experienced in the present study. To induce OspA 
downregulation, we increased BosR expression to a level that nearly kills B. burgdorferi.  Under 
this in-vitro condition OspA expression is significantly downregulated but is not completely shut 
down.   
The survival of B. burgdorferi within its two very distinct host environments demands 
deployment of complex survival strategies. All the adaptive changes taken up within its enzootic 
cycle are a consequence of dramatic differential gene expression of B. burgdorferi. Under the 
normal conditions, complete OspA downregulation occurs only during mammalian infection, in 
which OspC and other many RpoS-dependent osps are dramatically upregulated. The 
mammalian host apparently provides an extreme environment as these specific alternation 
signals might be unachievable under any in-vitro conditions. While either excessive RpoS or 
BosR expression is lethal to B. burgdorferi in-vitro, these high levels of expression may be 
essential for the pathogen to achieve downregulation of the ospA operon and to greatly 
upregulate RpoS-dependent virulence factors, and ultimately allow better survival of B. 
burgdorferi in the mammalian host. To achieve OspA downregulation in B. burgdorferi grown 
in-vitro, a high level of BosR expression in combination with simultaneous expression of OspC 
and other osps may be required. 
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As a key regulator, BosR, like RpoS, must be strictly regulated. The present study showed that 
BosR causes cell death when expressed at a very high level, just like RpoS (Chen et al. 2013).  
The cell death caused by excessive RpoS expression may be simply attributed to σ factor 
competition but there is no simple explanation for BosR-related death. While the biological 
significance of induced cell death remains to be addressed, at least one possibility should be 
considered, that is to control cell populations less diverse in the same environment.  For instance, 
the death strategy would select out subpopulations with a phenotype that overexpresses RpoS- or 
BosR-dependent genes during the stage in the tick vector. However, cell death resulting from 
increased RpoS or BosR expression is observed in-vitro. Given that B. burgdorferi cycles 
between the extremely different environments encountered in the tick vector and a mammal, in-
vitro growth conditions may only constitute an abnormal environment. It is possible that a high 
level of BosR and RpoS expression may provide an essential strategy for the pathogen to 
survive. Especially during infection of the mammalian host, B. burgdorferi may have to 
upregulate produce high levels of BosR to shutoff OspA expression and upregulate RpoS-
dependent virulence genes in order to adapt to the hostile environment inside host tissues.  
An RpoS-deficient background was chosen initially to rule out any involvement of RpoS in 
OspA downregulation, as a previous study suggested the alternative σ factor may be involved in 
regulation (Eggers, Caimano, and Radolf 2004).  BosR positively affects expression of many 
osps, including OspC and DbpA/B through activation of RpoS expression (Hyde et al. 2009, 
Liang, Nelson, and Fikrig 2002). We speculated that induced BosR expression might cause 
downregulation of OspA more effectively in 13A/bosRin than ΔrpoS/bosRin, as BosR also 
increases RpoS expression, which increases OspC and DbpAB expression and increased 
production of these osps would compensate for the loss of OspA.  However, the present study 
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showed that induced BosR causes OspA downregulation in ΔrpoS/bosRin than in the 13A/bosRin 
mutants, suggesting that gene regulation in B. burgdorferi is more complicated than believed 
previously. Our immunoblotting experiment showed that BosR expression is significantly 
stronger in the RpoS-deficient background than in the 13A/bosRin, suggesting that the presence 
of RpoS might exert a feedback pressure on BosR expression.    
BosR acts as a critical regulator as it directly binds the rpoS promoter region and activates rpoS 
transcription along with other regulators, RpoN and Rrp2. The current study demonstrated that 
BosR shuts off OspA expression by directly binding to the two regulatory sequences of the ospA 
operon. The question that how BosR can function as an activator as well as repressor remains to 
be investigated and thus may form a basis for future studies in the field. A previous study in our 
lab which identified cisI and cisII showed that these two elements could enhance ospA 
transcription in spirochetes cultured under in-vitro conditions. Although this enhancement was 
very minor, it supports the activator function of BosR. Thus there is another aspect to the 
regulatory function of BosR which remains to be uncovered when it is expressed at relatively 
low levels.  
In continuation to the previous publication from our lab which identified cisI and cisII as the 
genetic elements required for downregulation of ospA within the murine hosts (Xu, McShan, and 
Liang 2010); the present study elaborately demonstrates the repressor function of BosR for the 
ospA operon. This study demonstrates direct binding of BosR to both cisI and cisII regulatory 
elements and resulting into a complete shut down of OspA expression. This data contribute 
further to the series of studies by other groups showing that BosR directly binds to rpoS 
promoter region and causes upregulation of several RpoS regulated osps on the borrelial 
surface(Sears et al. 1991, Ouyang, Deka, and Norgard 2011). In conclusion BosR acts as an 
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important gene coordinator, which on one hand causes upregulation of RpoS-dependent OspC, 
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OUTER SURFACE LIPOPROTEIN LAYER HOMEOSTASIS 




Unlike other Gram-negative bacteria, which make a thick LPS (Lipopolysaccharide) coat or 
Gram-positive microorganisms, which cover and protect themselves with a strong cell wall, B. 
burgdorferi expresses lipoproteins and anchors them to the outer membranous surface through 
lipidation (Cullen, Haake, and Adler 2004, Fung et al. 1994, Xu et al. 2005).  Accumulating 
evidence indicates that B. burgdorferi maintains its overall surface lipoprotein expression during 
the entire enzootic life cycle i.e. travelling between the tick vector and a mammal, and during the 
course of mammalian infection.  The Lyme disease pathogen abundantly expresses outer surface 
protein A (OspA) in the unfed tick (Takayama, Rothenberg, and Barbour 1987, Liang et al. 2002, 
He et al. 2008, Xu et al. 2012). A fresh blood meal induces  downregulation of OspA and the 
upregulation of OspC and other osps, a process that prepares B. burgdorferi for infection in 
mammals (Schwan et al. 1995, Ohnishi, Piesman, and de Silva 2001, Liang, Nelson, and Fikrig 
2002, Purser et al. 2003).  Abundant OspC expression ultimately induces a robust early humoral 
response that imposes tremendous pressure on the pathogen (Schwan and Piesman 2000, Sears et 
al. 1991).  To evade the specific humoral response and cause persistent infection, B. burgdorferi 
down-regulates OspC, and dramatically upregulates other surface lipoproteins, including VlsE 
and BBF01  (Liu et al. 2009, Grimm et al. 2004, Mbow, Gilmore, and Titus 1999, Pal et al. 
2004).   
The outer surface lipoprotein expression is vital for B. burgdorferi as the failure to maintain 
appropriate surface lipoprotein expression can be of a lethal consequence (Xu, McShan, and 
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Liang 2008). B. burgdorferi highly expresses OspA in culture and shuts off the genes in response 
to overwhelming ospA repressing mammalian signals after introduction into the host. The 
inability to timely upregulate OspC to compensate for the loss of OspA and other osps results in 
quick elimination of the ospC mutant (Ohnishi, Piesman, and de Silva 2001). This occurs when 
OspC-deficient spirochetes are inoculated into mice.  Modification of the mutant with 
constitutive expression of any of the four lipoproteins, OspA, DbpA, VlsE or OspE, successfully 
rescues the ospC mutant with infectivity (Purser and Norris 2000).    
The importance of surface lipoprotein layer homeostasis was also observed in vitro, although 
interpreted in a different way, Yang and colleagues reported that inactivation of the ospA operon 
leads to constitutive activation of RpoS expression (de Silva et al. 1996) .  This occurs most 
likely as the alternative σ factor, RpoS, controls many outer surface lipoproteins, including 
OspC, DbpA/B, and BBK32 (Caimano et al. 2004, Caimano et al. 2005, Caimano et al. 2007). 
Thus, the deletion of the operon that encodes the two most abundantly expressed Osps in vitro 
(ospA) could be fatal to B.burgdorferi, unless other Osp(s) is dramatically upregulated to 
compensate for the loss of OspA.  As a result, only ospA mutants that happen to dramatically 
upregulate other osps can survive and be selected for further propagation. 
Although accumulating evidence supports the hypothesis that the outer surface lipoprotein layer 
homeostasis is an overwhelming force to override the normal regulatory programs, no 
experiments have been ever designed to specifically address this. In the present study, a series of 
experiments were designed to directly examine this hypothesis, in addition to showing osp 




Material & methods 
Strains and constructs that were generated previously and used in the current study   
B. burgdorferi B31 (strain 13A) was used as wild type strain. The ospA mutant (ΔospA) and 
ospA complement (ΔospA/ospA) were generated in a previous study (Xu, McShan, and Liang 
2008). The shuttle vector pBBE22 was a gift from S. Norris (Liang et al. 2004).  
2-D electrophoresis 
This analysis was performed using the Bio-Rad 2-D system (Bio-Rad, Hercules, and CA) 
following the manufacturer’s instructions.  Briefly, B. burgdorferi was grown to late log phase 
(approximately 108 cell/ml) in 1.0 ml BSK-H complete medium at 33oC and harvested by 
centrifugation 5,000 ×g for 3 min.  Resultant pellets were washed twice with 2-D washing buffer 
by centrifugation and resuspended in ~150 μl preheated (95°C) SDS sample solubilization 
buffer.  After sonication, the sample was heated at 95°C for 5 min, cooled to 20°C, diluted with 
~500 μl of 2-D sample solution, kept at room temperature for 20 min, and centrifuged at 14,000 
×g for 30 min at 20oC.  The protein concentration of the supernatant was determined and was 
adjusted at ~5 μg/μl with 2-D sample solution. 
First-dimension separation is performed by isoelectric focusing (IEF) electrophoresis. The pre-
made IPG strip from Bio-Rad were used. IPG strip was rehydrated in rehydration/equilibration 
trays followed by IEF with gel-side up. 
Second-dimension separation is SDS-page. Equilibrate the IPG strips twice, each time for 10 
min, in two different equilibration buffers. In sealing IPG Strips onto SDS-PAGE Gels, the 




Total Protein Staining was performed with Coomassie or SYPRO Ruby Protein Gel Stain. 
Mass spectrometry 
Selected proteins from 2-D gel were analyzed by gel trypsin digestion and Matrix-assisted laser 
desorption/ionization (MALDI TOF/TOF). MALDI was done in Nevada Proteomics Center, in 
Reno, Nevada. The Spots or bands were excised with robot and digested using a previously 
described protocol (Rosenfeld et al. 1992, Finehout and Lee 2003). Selected proteins from this 
step were also analyzed by gel trypsin digestion and MALDI TOF/TOF. Samples were washed 
twice with 25mM ammonium bicarbonate (ABC) and 100% acetonitrile, reduced and alkylated 
using 10 mM dithiothreitol and 100 mM iodoacetamide and incubated with 75 ng sequencing 
grade modified porcine trypsin (Promega) in 25 mM ABC overnight at 37o C.  Digested samples 
were spotted onto a MALDI target with ZipTipµ-C18 (Millipore Corp., MA) and eluted with 
70% acetonitrile, 0.2% formic acid and overlaid with 0.5 μL of 5 mg/ml MALDI matrix (α-
Cyano-4 hydroxycinnamic acid 10 mM ammonium phosphate).  All mass spectrometric data 
were collected using an ABI 4700 Proteomics Analyzer MALDI TOF/TOF mass spectrometer 
(Applied Biosystems, CA), using their 4000 Series Explorer software v. 3.6.  The peptide masses 
were acquired in reflectron positive mode (1-keV accelerating voltage) from a mass range of 650 
– 4000 Daltons, 1250 laser shots were averaged for each mass spectrum.  Each sample was 
internally calibrated on trypsin’s autolysis peaks 842.51 and 2211.10 to within 20ppm.  Any 
sample failing to internally calibrate was analyzed under default plate calibration conditions of 
150ppm. Raw spectrum filtering/peak detection settings were S/N threshold of 3, and cluster area 
S/N optimization enabled at S/N threshold 10, baseline subtraction enabled at peak width 50. The 
twenty most intense ions from the MS analysis, which were not on the exclusion list, were 
subjected to MS/MS. The MS/MS exclusion list included known trypsin masses: 842.51, 870.54, 
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1045.56, 1126.56, 1420.72, 1531.84, 1940.94, 2003.07, 2211.10, 2225.12, 2239.14, 2283.18, 
2299.18, 2678.38, 2807.31, 2914.51, 3094.62, 3337.76, and 3353.75.  For MS/MS analysis the 
mass range was 70 to precursor ion with a precursor window resolution of -1 to +4 Da with an 
average 2500 laser shots for each spectrum, CID ON, metastable suppressor ON. Raw spectrum 
filtering/peak detection settings were S/N threshold of 5, and cluster area S/N optimization 
enabled at S/N threshold 6, baseline subtraction enabled at peak width 50. The data was then 
stored in an Oracle database (Oracle database schema v. 3.19.0 Data version 3.90.0). 
MALDI data analysis 
The data was extracted from the Oracle database and a peak list was created by GPS Explorer 
software v 3.6 (Applied Biosystems) from the raw data generated from the ABI 4700. Analyses 
were performed as combination of MS + MS/MS.  MS peak filtering included mass range 650-
4000 Da, minimum S/N filter 10.  A peak density filter of 50 peaks per 200 Da with a maximum 
number of peaks set to 65.  MSMS peak filtering included mass range of 60 Da to 20 Da below 
each precursor mass.  Minimum S/N filters 10, peak density filter of 50 peaks per 200 Da, cluster 
area filter used with maximum number of peaks 65. The filtered data were searched by Mascot v 
2.2.04 (Matrix Science) using NCBI nr database (NCBI 2009), containing 8,080,522 sequences. 
Searches were performed without restriction to protein species, Mr, or pI and with variable 
oxidation of methionine residues and carbamidomethylation of cysteines.  Maximum missed 
cleavage was set to 1 and limited to Trypsin cleavage sites.  Precursor mass tolerance and 
fragment mass tolerance were set to 20 ppm and ± 0.2 Da, respectively. These files were then 




 RNA preparation 
Spirochetes grown to late log phase (approximately 108 cell/ml) in 40 ml of BSK-H medium at 
33°C were harvested by centrifugation. Total RNA was extracted using RNA Isolation Kit 
following the manufacturer’s instruction & (Qiagen). Genomic DNA was removed through 
DNase I digestion. The rRNAs were depleted using Microb Express Kit (Ambion).  The RNA 
concentration was determined by using ND-1000 (Nano Drop Technologies).  
Real time RT-PCR    
The real time RT-PCR was performed using SYBR green PCR Kit and following its instructions. 
After extracting RNA from borrelia culture, cDNA from total RNA was synthesized using, 2 µg 
RNA and oligo-dT for reverse transcription reaction. The DNA-free RNA preparation was first 
annealed with oligo-dT (In-vitrogen) at 42˚C for 2 min, in presence of reverse transcription (RT) 
buffer (In-vitrogen). Deoxynucleoside triphosphates and SuperScript II Rnase H- reverse 
transcriptase was added, RT was conducted at 42˚C for 1 h, and then reaction was terminated by 
heat inactivation of enzyme at 70˚C for 15 min according to manufacturer's instructions. The 
cDNA preparation was diluted with nuclease free water and aliquoted into small tubes and stored 
at -80˚C until further use. 
Using the real time PCR primers (Table 3.1) and iTaq™ SYBR® Green Supermix with ROX 
(Bio-Rad, Hercules, CA), real time PCR was performed on Applied Biosystems GeneAmp PCR 
System 7900. The primers were designed to amplify sequences ranging from100-200 bps. The 
absolute and relative quantitation of target RNA was calculated by comparing result data of 
samples with standard curve of target and reference gene. The borrelia flaB gene was used as the 
reference gene. All cDNA amplification reactions were carried out in 20µl volume in a 96-well 
78 
 
PCR plate, each sample was run in triplicate. Amplification was achieved with following 
parameters: 95˚C for 10 min, and 40 cycles of 95˚C for 15 s and 60˚C for 1 min. The mean 
cDNA copy numbers of each sample, transcripts of each cDNA pool were automatically 
calculated from triplicate wells using SDS 1.4 software. Gene expression levels were presented 
as mRNA copy number per 103 flaB mRNA transcripts. 
Protein extraction and SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
For one dimensional SDS-PAGE, cell pellets were suspended in HN buffer containing protease 
inhibitor cocktail (Roche), sonicated with a Branson Digital Sonifier for 4 cycles each of 15 sec 
burst followed by 1 min rest. After centrifugation at 10,000xg, supernatants were analyzed by 
electrophoresis according to Laemli method using 12% TGX gel (BioRad) in Tris-glycine buffer 
system for 2h at 80 volts. Gels were then stained with Bio-Safe Coomassie G-250 stain for 
visualization of protein bands. 
Immunoblot Analysis  
The protein bands in SDS-PAGE gel were electrotransferred onto a nitrocellulose membrane 
(Thermo Scientific, Rockford, IL). Different borrelial proteins (Figure 3.4 &3.5) were probed 
with either a mixture or individual Monoclonal Antibodies (MAbs). The α-FlaB, were used as 
positive control and used at 1:100 dilution (Barbour et al. 1986). The α-OspC, α-DbpA, α-RpoS, 
and α-BosR MAbs were used in 1:10000 dilution. The α-OspC were developed by Mbow et al. 
in 1999 (Mbow, Gilmore, and Titus 1999). The α-RpoS was kindly provided by F. Yang (Indiana 
University School of Medicine) and the α-BosR MAbs were provided by Xin Li (Department of 
Veterinary Biosciences, The Ohio State University). 
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The secondary antibody used was the commercially available goat anti-mouse IgG conjugated 
with horseradish peroxidase (hrp) at 1:5000 final dilution (ThermoScientific, Waltham, MA). 
The commerically available Coloroimetric blotting substrate (4CN) was used to develop 
nitrocellulose membrane (Kirkegaard and Perry Laboratories, Gaithesburg, MD). 
Table 3.1. Primers used in the study: All the primers designed for qPCR covered 100-200 bps of 
the respective genes. 
Primer   Sequences (5’ to 3’)                                                                     Purpose 
 flaBqf CATATCTTGGAGACAGACGTAGACTTATACACGG qPCR 
 flaBqr    CTGCATTCCAAGCTCTTCAGCTGTTC qPCR 
 ospDf1 AGGCAAATAAAGTTGTAGAAGCGGT qPCR 
 ospDr2 TTCTGCCATTTGAGCTAAATCATGC qPCR 
 bbj41f AACCGAAGAATAGCTGGTCAA qPCR 
 bbj41r TTGTAGCAACTTTTCGGCTTCT qPCR 
 ospDf2 GAA GGC GCA AAT TCA AAT TAC GAA TC lp38 identification 
 ospDr2 CAG CAG AAT CAG AAT AGT CAG ATT C lp38 identification 
 
Selection of B. burgdorferi with lost lp38 (ospA/lp38-)  
The ospA knockout mutant was cultivated to late logphase in 10 ml BSK-H media at 33ºC, 
pelleted by centrifugation and resuspended after washing with media. The pellet was 
resuspended in 50 ml of fresh media and aliquoted for obtaining single borrelial colonies. All the 
resultant clones were screened by PCR for presence of lp38 using primers as shown in table 3.1. 
The PCR conditions included: 94 °C for 1 min; 94 °C for 64  seconds, 54 °C for 30 seconds, 72 
°C for 1 min, 35 cycles; 72 °C for 10 min. PCR products were separated on an ethidium 
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bromide-agarose gel. The selected clones were first surveyed for the presence of lp28-1 because 
this plasmid is essential for persistent infection of immunocompetent hosts (Fingerle et al. 2007, 
Crother et al. 2004, Barbour et al. 1986).  Only clones containing lp28-1 were further analyzed 
for Osp expression study.  
In-vitro characterization of selected clones 
The selected ospA mutants lacking lp38 were grown in Barbour-Stoenner-Kelly H (BSK-H) 
complete medium (Sigma Chemical Co., St. Louis, MO) to late-log phase at 33oC, and harvested 
by centrifugation.  Spirochete lysates were subjected to immunoblot analysis probed with FlaB 
(Raetz and Whitfield 2002), OspA (Xu, McShan, and Liang 2007) or OspC mAb (Xu, McShan, 
and Liang 2007). Immunoblotting was performed as described (Sears et al. 1991). 
Microscope image 
The wild type B. burgdorferi 13A, ospA mutant (ΔospA), both strains with and without lp38 
(ΔospA/lp38+ & ΔospA/lp38-) and the ospA complement (ΔospA/ospA) spirochetes were grown 
to early log phase (107 cells/ml) in BSK-H medium at 33°C and harvested by centrifugation from 
1.0 ml culture. The harvested spirochetes were resuspended in 20µl PBS and then charged onto 
fresh glow-discharged holey carbon grids for 1 min. A filter paper was used to blott the Grids 
were and then rapidly frozen in liquid ethane, using a homemade gravity-driven plunger 
apparatus. Polara G2 electron microscope, with field emission gun and a 16 megapixel camera, 
operated at 300 kV was used for imaging the frozen-hydrated samples at -170°C (FEI Co., 






The qPCR data was analyzed using a one-way analysis of variance (ANOVA), followed by a 
two-tailed Student t test to compare both conditions and calculate P values of ≤ 0.05 were 
considered to be significant. Fisher’s exact test was used to analyze tissue colonization data. 
GraphPad Prism 5.0 was used for calculations (GraphPad Software Inc., La Jolla, CA) 
Results 
Deletion of the ospA locus leads to dramatic up-regulation of OspD and BBJ41 and 
complementation reduces their expression to an undetectable level  
The protein analysis of an ospA mutant showed two protein bands that were substantially up-
regulated (Figure 3.1).  Complementation of the mutant with the ospA gene alone repressed the 
two polypeptides to an undetectable level.  As OspA are such highly expressed Osps, not 
regulators, when B. burgdorferi is grown in vitro, these observations led us to hypothesize in 
previous study that the outer surface lipoprotein layer is required for basic survival of the 
spirochete and its homeostasis is an overwhelming force to gene regulation (Xu, McShan, and 
Liang 2008).  Based on the previous study we hypothesised that the two highly upregulated 
protein bands as shown in figure 3.1 may be that of some other outer surface lipoproteins that 
might have been up-regulated in ospA mutant to compensate for the loss of OspAB and 




Figure3.1. Disruption of the ospA locus leads to dramatic upregulation of OspD and BBJ41, and 
complementation with ospA causes their downregulation to an undetectable level.  The two 
greatly upregualated protein bands were initially unidentified. Proteins were further purified by 
using 2-D gel electrophoresis, and identified as outer surface lipoproteins OspD and BBJ41by 
MS-Spect analysis. 
 
Identification of two highly upregulated proteins as OspD & BBJ41 in ospA knockout 
(∆ospA): 
The two highly upregulated polypeptides were separated using 1-D (Figure 3.1) and 2-D gel 
electrophoresis (Figure3.2).  Purified protein Spots or bands were excised with robot and 
analyzed by MS-Spect. The MS-Spect analysis identified the two highly upregulated proteins to 
be 28kDa OspD (spot 1’/1, 2’/2, and 3’/3) and 35kDa BBJ41 (spot 5’/5) both expressed as outer 
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surface lipoproteins in B. burgdorferi. Additionally, OspD and BBJ41 were also identified on 1-
D gel directly using same method (Figure 3.1). 
 
Figure 3.2. The 2-D gel electrophoresis for wild type B. burgdorferi 13A & OspA knock out.(A) 
2-D gel image for wild type strain 13 A  of Borrelia burgdorferi.(B)2-D gel image for ospA 
mutant. MS-Spec analysis revealed Spots 1’/1, 2’/2, and 3’/3 as OspD; Spot 4’/4 as GAPDH. 






Over expression of identified protein at mRNA level 
 The dramatic regulation of OspD and BBJ41 was further confirmed at the mRNA level.  RNA 
was extracted from the parental strain 13A, ∆ospA and ∆ospA/ospA and analyzed by qRT-PCR. 
As shown in figure 3.3, the expression level changed 16 and 21 times for ospD and bbj41, 
respectively. These results clearly show that expression of OspD and BBJ41 is highly increased 
at the mRNA level in absence of ospA, thus indicating that absence of OspA is compensated by 
upregulation of OspD and BBJ41. 
 
Figure 3.3. Absence of ospA causes increased expression of Outer surface lipoproteins, OspD & 
BBJ41 at mRNA level: (A) qRTPCR results for ospD show 16 fold rise in mRNA copy and (B) 
qRTPCR results for bbj41 show 21 fold rise in mRNA copy in comparison to the wild type 13A 
strain of B. burgdorferi.  
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Deprivation of lp38, the plasmid that carries the ospD and bbj41 genes, leads to constitutive 
expression of RpoS and its dependent Osps 
In order to continue to address the hypothesis that homeostasis of the Osp layer overrides the 
normal regulatory program, we initially attempted to inactivate both ospD and bbj41 genes.  As 
the plasmid lp38, which carries both the genes, is not essential for infection and may be easily 
lost, we designed experiments to isolate clones that lose the plasmid. A total of 56 clones were 
selected; only one of them, namely ΔospA/lp38-, had lost lp38. The 13A, ΔospA, and ΔospA 
(lp38-) spirochetes were grown to early log phase, harvested, analyzed by SDS-PAGE, and 
stained with Coomassie staining (Figure3.4A) and probed by immunoblotting with α-FlaB & α-
OspC (Figure 3.4 B & C). The protein analysis below clearly show that OspC is induced in ospA 
mutant lacking lp38, these results indicate that OspC is upregulated in response to an absence of 
OspA, OspD & BBJ41. As OspC expression is induced by RpoS, we further analysed ospA 
mutant without lp38 for presence of other RpoS induced Osps. Hence immunoblotting with α-
DbpA was done (Figure3.4D). Taken together these results indicate that absence of major Osps 
caused induction of RpoS and hence the RpoS regulated Osps, OspC & DbpA, thus maintaining 
the surface homeostasis and overriding usual regulatory mechanisms and ensuring the survival of 





Figure 3.4. Depletion of lp38, the plasmid that carries both ospD and bbj41 genes, leads to 
constitutive RpoS activation as well as dramatic upregulation of RpoS-dependent osps. The 
ΔospA culture was subcloned through a serial dilution.  A total of 56 clones were selected; only 
one of them, namely ΔospA (lp38-), lost lp38.  The 13A, ΔospA, and ΔospA (lp38-) spirochetes 
were grown to early log phase, harvested, analyzed by SDS-PAGE, and stained with Coomassie 
staining (A) and immunoblotting probed with (B) flaB, (C) RpoS, and (D) DbpA antibodies. 
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Complementation of ΔospA (lp38-) with ospA represses constitutive expression of RpoS and 
its dependent osps 
RpoS is continuosly expressed throughout the mammalian phase of Lyme disease, it regulates 
many important mammalian phase Osps, including OspC, DbpA/B and BBK32. The 
experimental results above show that RpoS is induced in vitro in the absence of major tick phase 
Osps like OspA & OspD.  To ensure that RpoS was induced in a compensatory response to the 
absence of major Osps like OspA, we complemented ospA mutant lacking lp38 with ospA 
plasmid. Complementation of ospA mutant resulted in reduced expression of RpoS upregulator 
BosR, hence RpoS and OspC (Figure 3.5). These results clearly indicate that RpoS was induced 
in ospA mutant lacking lp38 as the osp layer homeostatic response in B.burgdorferi. 
Figure 3.5. Complementation of ospA mutant represses BosR which represses RpoS and hence 
the RpoS induced OspC. (A) Coomassie stained SDS-PAGE showing clear reversal of 
compensatory OspC expression on complementation of ospA mutant with pBBE22-ospA. (B) 
Immunoblot probing with α-FlaB, α-OspC, α-RpoS, and α–BosR antibodies indicate significant 




Homeostasis of the Osp layer 
The advanced technology of cryo-electron microscopy allowed the observation of the density of 
the outer surface lipoprotein layer directly under cro-te. (Figure 3.6). The microscopic images 
clearly show that the density of osp layer did not change under distinct conditions with regard to 
the different dominant osps. All the B. burgdorferi strains including wild type 13A, ospA mutant 
lacking lp38 (consequently lacking OspD, BBJ41 & OspA) and ospA mutant retaining lp38 show 
similar density of osp layer (Figure 3.6). The same results are supported by the above 
experimental results which showed that the ospA mutant lacking lp38 induces RpoS and hence 
RpoS regulated osps like OspC & DbpA. This enables ospA mutant to retain contant osp layer 
density. Similarly in the ospA mutant with lp38, the overexpression of OspD and BBJ41 
compensates for the loss of OspA and the density of the osp layer remains unchanged even in the 
absence of dominant ospA locus.  
 
Figure 3.6. The overall density of the osp layer remains unchanged irrespective of the expression 
levels of each individual osp. The 13A, ΔospA and ΔospA/ospA spirochetes were grown to early 
log phase and imaged using the Polara G2 electron microscope. Images A & E show osp layer 
for wild type B. burgdorferi 13A, Images B & F show osp layer for ΔospA lacking ospD 
containing lp38, Images C and G show osp layer for ΔospA/ospA, and Images D and H shows 
proteinase treated wild type B. burgdorferi completely lacking the osp layer.  
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All these results taken together indicate that the osp layer in B. burgdorferi exists in a state of 
homeostasis. The regulation of this homeostasis takes priority over the normal osp expression 
and loss of one osp is compensated by expression of another osp. 
 
Discussion  
One feature of the Lyme disease spirochete, Borrelia burgdorferi, is to abundantly express outer 
surface lipoproteins (osps) and to form a lipoprotein layer to coat itself (Beck et al. 1985, Radolf 
et al. 1994). It has been known for years that the spirochete constantly modifies the component 
of the antigen layer to adapt to diverse environments and evade the immune system (Schwan 
2003, Gutierrez Fernandez et al. 1997, Barbour 1991, Koomey 1997). A previous study has 
shown that maintenance of surface lipoprotein coat is central to survival of spirochete (Xu, 
McShan, and Liang 2008). However, the knowledge of interplay amongst several Outer surface 
lipoproteins is still incomplete and is a matter of investigation in borrelia research. 
 OspA is the most dominantly expressed osp when B. burgdorferi resides in tick and is grown in-
vitro. During the generation of the ospA mutants in a previous stuy, it was noticed that, 
inactivation of ospA gene was more difficult than any other osp genes. Furthermore, it was 
observed that the ospA mutants grow unhealthily in vitro (Barbour et al. 1986). One explanation 
to these observations during the generation of ospA mutant can be that absence of OspA would 
cause a dramatic reduction in the density of the osp layer and hence ospA mutants that are not 
able to upregulate other osps in compensation of OspA fail to thrive well. Hence, deletion of 
ospA is lethal if the spirochetes do not increase the expression of other osps to compensate for 
the loss (Barbour et al. 1986).   
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The current study reconfirmed that the integrity of the lipoprotein layer is crucial for the basic 
survival of B. burgdorferi and that the requirement for maintaining this integrity is above the 
normal regulatory programs. The deletion of the ospA locus, which encodes the two most 
abundantly expressed osps when B. burgdorferi is grown in vitro or inhabits the tick vector 
(Howe, Mayer, and Barbour 1985, Beck et al. 1985), led to dramatic increase in expression of 
two other osps, namely OspD and BBJ41. Hence it can be stated that osps compensate for each 
other in order to maintain constant surface lipoprotein coat. 
This was further corroborated as the complementation with the ospA gene alone completely 
repressed the two highly upregulated osps to an undetectable level and depletion of lp38, the 
plasmid that carries both ospD and bbj41, resulted in a constitutive expression of RpoS and its 
dependent osps like OspC. In addition to the above observations, the complementation of the 
lp38-deficient ospA mutant with ospA led to a significant repression of the constitutively 
expressed RpoS and its dependent osps.  
 Finally, the hypothesis regarding constant homeostatic maintenance of surface lipoprotein coat 
was confirmed by cryo-electron microscopy, which showed that the density of the osp layer 
remains constant regardless of expression levels of individual osps. Taken together, the study 
demonstrated that outer surface lipoprotein layer homeostasis overwhelms regulatory programs 
in B. burgdorferi. This theory should help in interpretation of many experimental results, such as 
inactivation of a major osp would lead to great upregulation of other ones. The understanding of 
interplay amongst different osps in biology of B. burgdorferi, may lead to new approaches for 
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GENERAL CONCLUSIONS AND DISCUSSION 
Lyme disease is currently the most commonly reported vector borne disease in the United States 
(Bacon et al. 2008). The causative agent of Lyme disease B. burgdorferi sensu stricto, is mainly 
responsible for the disease in North America. In its North American  cycle, B. burgdorferi 
mostly gets transmitted amongst small mammals (Levine, Wilson, and Spielman 1985). 
However, the Lyme disease transmission to humans is accidental and they act as the dead-end 
host. The bite of infected Ixodes scapularis on the east coast (and mid central) and Ixodes 
pacificus on the west coast (Anderson 1989, Anderson and Magnarelli 1980, Barbour 1998) acts 
as the main mode of transmission of Lyme disease.  
The need of rapid adaptation to the discrete invertebrate and mammalian environments elicit 
impressive genetic manipulation by B. burgdorferi. The small genome of B. burgdorferi is 
coordinated by an intricate molecular mechanism still incompletely known and understanding 
the molecular mechanism of borrelial adaptation may lead to identification of suitable targets for 
development of effective Lyme disease prevention strategies.   
In order to adapt and survive in the disparate environments B. burgdorferi has to differentially 
regulate its whole transcriptome, this global adjustment is accomplished through the use of RNA 
polymerase sigma factors. The genome of B. burgdorferi encodes only three sigma factors, the 
constitutive sigma factor RpoD (σ70), and two alternate sigma factors, RpoN (σ54) and RpoS (σS) 
(Fraser et al. 1997). The alternate sigma factors form a well-coordinated cascade where rpoS 
depends on RpoN for its transcription, which in turn relies on Rrp2 a phosphorylation activated 
protein (Yang, Alani, and Norgard 2003, Smith et al. 2007).  
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BosR is a recent addition to the key regulatory molecules known for the regulation of RpoN-
RpoS pathway. Other than bosR itself, rpoS and napA/bicA are the only two other known genes 
that are directly activated by BosR (Ouyang et al. 2009, Wang et al. 2012). The previous studies 
have shown that the downregulation of OspA is mediated indirectly through RpoS via a DNA 
binding repressor molecule (Caimano et al. 2005). The present study shows that BosR can 
directly bind to the upstream regulatory sequences of ospA and ospD genes. It also proves that 
BosR causes direct repression of OspA by binding to cisI and cisII regulatory elements (Xu, 
McShan, and Liang 2010). Thus, this study provide sufficient evidence to support the hypothesis, 
that OspA downregulation is not essentially RpoS dependent and BosR  acts as a direct repressor 
for OspA. 
 Furthermore, the present study also indicates that BosR mediates complete shut off of OspA 
only when the constitutive expression of other surface lipoproteins (OspC, DbpA and DbpB) is 
provided. This can be explained by the putative homeostasis existing on the outer surface 
membrane of B. burgdorferi.  The surface lipoproteins play a protective role and hence 
downregulation of a major surface lipoprotein like OspA may not be complete till borrelia has 
other Osps to compensate (Yang et al. 2004, Xu, McShan, and Liang 2008). Even in the natural 
infectious cycle OspA downregulation is not 100%. As B. burgdorferi prepares to infect the 
mammalian host, downregulation of OspA occurs only in about 50% of the total spirochete 
population colonizing the tick midgut before migration to the tick salivary glands (Ohnishi, 
Piesman, and de Silva 2001). Hence OspA shutoff is difficult for B. burgdorferi even in nature. 
 Most of the differentially regulated genes in borrelia that participate in the adaptive response to 
an external environmental change, encode for one or the other outer surface lipoprotein. Being an 
interface between external and internal environment, outer surface lipoproteins play a central 
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role in survival adaptations of B. burgdorferi (Xu, McShan, and Liang 2008). Furthermore, there 
have been several studies which have pointed the homeostatic balance in osp expression on the 
outer membrane of B. burgdorferi. One such study showed that the deletion of the ospA operon 
caused constitutive activation of the Rrp2-RpoN-RpoS pathway and hence osps controlled by it 
like OspC, DbpA and DbpB (He et al. 2008). In another such study, the ospA mutant appeared to 
have increased expression of several outer surface lipoproteins, but none of these were RpoS 
regulated (Battisti et al. 2008). Similarly, an ospC mutant showed upregulation of several other 
lipoproteins regulated by the RpoS regulon (Pal et al. 2004). The present study proves the 
existence of osp layer homeostasis and presents two new osps, OspD and BBJ41, wich 
compensate for the absence of dominat OspA and maintain outer surface homeostasis. 
Many putative lipoproteins encoded by B. burgdorferi have been implicated in corroborating tick 
vector colonization and disease transmission, however, precise mechanisms and function of most 
of these remains largely unknown. The present study adds to knowledge of osp regulation as it 
shows how BosR acts a repressor for OspA.   
In the natural infectious cycle the downregulation of OspA on surface is compensated by 
upregulation of OspC as B. burgdorferi prepares to infect the host. This crossregulation of OspA-
OspC has been demonstrated as a key factor for causing infection in mammalian host. Further in 
its infection phase, borrelia downregulates even OspC and replaces it by VlsE outer surface 
protein. Thus, broadly, Osps of borrelia protect it from mammalian immune system, enable its 
successful persistence in tick vector and ensures continuation of the natural infection cycle (Xu, 
McShan, and Liang 2008). 
Exact regulatory mechanisms involved in controlling the osp expression are complex and still 
largely unknown. However, OspA is one such significant osp which forms a dominant 
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expression on the surface while B. burgdorferi lies dormant in an unfed tick midgut, it is rapidly 
downregulated in response to blood meal from an uninfected mammalian host. The rapid 
downregulation of OspA is important to protect borrelia from mammalian immune system as the 
antibodies against OspA once produced can eliminate B.burgdorferi from it enzootic cycle. 
Therefore, OspA has been an attractive target for development of vaccine against Lyme disease 
and, also a vaccine using an immunogenic recombinant B. burgdorferi outer surface protein 
(OspA) was licensed by the US Food and Drug Administration (FDA). Unfortunately, vaccine 
was withdrawn citing multiple concerns. Understanding the differential regulation of ospA may 
lead us for identification of additional target for disruption of the homeostasis of outer surface 
proteins required for the survival of borrelia in different host environment. The present study 
deals specifically with questions pertaining to downregulation of OspA and what happens on 
borrelial surface in its absence. 
While the incidence of Lyme disease continues to increase along with its expanding endemic 
area, the ambiguous clinical manifestations still pose a challenge to early diagnosis of Lyme 
disease. Though antibiotic therapy is currently available for treating Lyme disease in early 
stages, it is still not successful in treating antibiotic refractory Lyme arthritis and post lyme 
disease syndrome (chronic lyme disease). Hence the current tools for prevention, diagnose, and 
treatment of Lyme disease are limited.  
The main goal for the studies described in this dissertation is to delve further into the molecular 
mechanisms of differential gene regulation and function of outer surface lipoprotein in the 
infectious life cycle of B. burgdorferi. One part of this study adds to such observations where the 
absence of OspA in an ospA deficient B. burgdorferi is compensated by increased OspD and 
BBJ41 expression. Both these tick phase surface lipoproteins are not expressed in mammalian 
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host and need to be investigated for their potential as vaccine targets. The electron microscopy 
results clearly show maintenance of constant lipoprotein density on the outer membrane layer in 
B. burgdorferi irrespective of the osp gene mutation. This study for the first time clarifies well 
speculated homeostatic osp maintenance on the borrelial surface, which is critical for 
development of intervention strategies for the Lyme disease. Our study has re-emphasized the 
need for further investigations into the alternative mechanisms of downregulation of OspA, 
independent to RpoS. 
Understanding the gene regulation and outer surface lipoprotein layer functioning can potentially 
provide important targets for interrupting B. burgdorferi infectious cycle and development of 
vaccine against Lyme disese. 
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